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This dissertation is dedicated to my mom. And for others with chronic illness who
struggle to maintain quality of life.

“Hope” is the thing with feathers –
That perches in the soul –
And sings the tune without the words –
And never stops – at all –

And sweetest – in the Gale – is heard –
And sore must be the storm –
That could abash the little Bird
That kept so many warm

I’ve heard it in the chilliest land –
And on the strangest Sea –
Yet, never in Extremity,
It asked a crumb – of Me.
Emily Dickinson (C.1891/1960)
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ABSTRACT
HEALTH-PROMOTING BEHAVIORS, HOPE, AND HEALTH-RELATED QUALITY
OF LIFE IN PERSONS IMPACTED BY PARKINSON’S DISEASE

AMY FORBES
2017

Objective: The purpose of the study was to determine the relationship between hope,
health-promoting behaviors, and health-related quality of life (HRQOL) in persons with
Parkinson’s disease.
Background: The incidence of Parkinson’s disease is high in Midwest and Northeast
regions of the United States. Parkinson’s disease affects motor and non-motor symptoms
and has a variety of complications. Parkinson’s disease is related to genetic and
environmental factors. HRQOL decreases in Parkinson’s disease; thus, the effect of hope
and health-promoting behaviors on health is crucial as the disease advances.
Methods: A descriptive correlational design was used to guide the study. A convenience
sample of persons with Parkinson’s disease who completed three questionnaires was used
to measure health-promoting behaviors and HRQOL while modifying for disease
severity.

Results: Exploratory factor analysis was used to examine dimensions of hope, healthpromoting behaviors (HPLP), and HRQOL. Confirmatory factor analysis determined
goodness of fit for the structure of the study data. The construct reliability of the
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confirmed factor structure model showed an adequate inter-item consistency (Cronbach’s
alpha 0.70, QOL = .792, HPLP = .857, and hope = .844). After meeting the assessment of
the reliability test, convergent validity, discriminant validity and confirmation of model
fit of the factor model, a summated scale or a composite variable was created. The
summated scale variables met five assumptions of the multivariate regression method to
assess for appropriateness of method used. Finally, a path analysis was constructed where
together hope and HPLP explained about 62% of the variation of scores within the
dependent measure in HRQOL. Hope became non-significant statistically, with the
inclusion of HPLP. Effects of varying stages of disease severity and its relation to the
direct effects of hope and HPLP to the dependent measure in HRQOL was contemplated.
Conclusions: This study advances knowledge regarding the relationship between
hope, HPLP, and HRQOL in persons with Parkinson’s disease. The increased knowledge
raises awareness of the importance of hope and health-promoting behaviors despite
various stages of disease severity.
Key words: hope, health-promoting behaviors, health-related quality of life,
Parkinson’s disease, factor analysis
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CHAPTER 1: INTRODUCTION AND BACKGROUND
Phenomenon of Interest
Parkinson’s disease is a chronic, progressive neurological disease that afflicts
more than one million Americans, a number expected to double by 2030 (National
Parkinson’s Foundation [NPF], 2015). The main symptoms of Parkinson’s disease
include bradykinesia, rigidity, and tremors. These motor symptoms respond well to
treatment in the early stages, but the disease also has non-motor symptoms and is
progressive with a variety of complications (Winter et al., 2010). Parkinson’s disease is
the second-most common neurodegenerative disorder, after Alzheimer’s disease (NPF,
2015). About 60,000 new cases of Parkinson’s disease are diagnosed each year in the
United States, and this number does not include the large number of cases that go
undetected (Parkinson’s Disease Foundation [PDF], 2016). The incidence of Parkinson’s
disease is projected to triple by 2050, an increase that is directly related to the aging
population and the increased risk of developing Parkinson’s disease with age. Peak
incidence of the disease is typically between 70 and 79 years of age, but four percent of
persons with Parkinson’s disease have early onset, which is diagnosed before age 50
(PDF, 2016).
The Midwest and Northeast regions of the United States have a Parkinson’s
disease belt with higher prevalence and incidence of the disease in a nonrandom
distribution. These regions report that the rate of Parkinson’s disease is up to 10 times
greater than other geographic areas in the United States. In addition, there is case
clustering in the Midwest. Nebraska has the highest incidence of Parkinson’s disease in
the United States, affecting 329.3 per 100,000 people. In addition, South Dakota, North
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Dakota, Minnesota, and Iowa have the highest incidence of people with Parkinson’s
disease in America. These rural states are also recognized for their high agriculture
productivity and use of heavy insecticides and pesticides in farming areas (American
Parkinson’s Disease Association [APDA], 2012). According to the South Dakota
Parkinson Foundation (2016) there are 3,000 persons in South Dakota that have
Parkinson’s disease.
Both genetic and environmental factors contribute to the likelihood of contracting
Parkinson’s disease. Although men are one-and-a-half times more likely to develop
Parkinson’s than women, research is not conclusive about whether this difference is due
to genetics, hormones, or behavioral differences (NPF, 2015). Two thirds of patients with
Parkinson’s disease have no family history of the disease (Center for Disease Control
[CDC], 2015). Having a first-degree relative with Parkinson’s, such as a parent or sibling,
increases the risk of Parkinson’s disease by four percent to nine percent compared to the
general population (NPF, 2015). Thirteen gene mutations are associated with Parkinson’s
disease. Environmental factors alone do not cause Parkinson’s disease unless there is also
a genetic risk. A common analogy relating the causative factors for Parkinson’s disease is
that genetics is the gun, but something in the environment pulls the trigger (PDF, 2016).
Exposure to pesticides, chemicals such as manganese, rural living, farming, and
well water are all known environmental risks that increase the rate of Parkinson’s disease
(NPF, 2015; Owens, 2008). Ethnically similar individuals who are genetically
susceptible to Parkinson’s disease reside in this area of the country (Wright Willis,
Evanoff, Lian, Criswell, & Racette, 2010). For example, the Spellman-Muenter family in
Iowa links 200 cases of Parkinson’s disease to kindred who have genes associated with

3
Parkinson’s disease (Gwinn, 2009). Furthermore, both the area of the country (which
relates to the exposure of environmental toxins) and a person’s ethnicity (which increases
genetic risk) may lead to an increase of Parkinson’s disease for people in the Midwest
and Northeast regions of the United States.
Health-Related Quality of Life
Quality of life often decreases when a person goes through an experience as is
threatened can a person understand the important connection between humanity and
human dignity. Patients with Parkinson’s disease often lose dignity when they are no
longer able to care for themselves, interact with their families, or participate in their
communities, thereby rendering them without a sense of belonging. When people
maintain health-related quality of life (HRQOL) and increased hope, they also maintain
their dignity. According to the American Nurses Association (ANA, 2015), nurses are
obligated to uphold the first provision of the Code of Ethics for nurses and act with
compassion and appreciation for human dignity (p. 1). This underlying provision respects
the patient’s basic needs, values, and lifestyle, and ultimately leads to an overall
betterment of humanity.
Parkinson’s disease is associated with daily physical limitations, compromised
communication, and eventual decreased cognitive functioning. Parkinson’s disease
affects more than physical functioning; it also contributes to psychosocial
malfunctioning. According to Welsch et al. (2003), depression, anxiety, and decreased
social interaction are common in patients with Parkinson’s disease. All of these factors
may decrease HRQOL. Along with the decline in motor symptoms, non-motor
symptoms, such as depression, anxiety, and cognitive impairment, as well as fatigue,
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pain, sleep, and bladder problems, contribute to lower HRQOL (Kadastik-Eerme,
Rosenthal, Paju, Muldmaa, & Taba, 2015).
HRQOL includes the following domains: physical functioning, physical role,
bodily pain, general health perceptions, vitality, social functioning, emotional
functioning, and mental health (Sigstad, Stray-Pederson, & Froland, 2005). In contrast to
acute diseases wherein a cure is the ultimate goal, the goal of treating Parkinson’s disease
is to minimize symptoms and improve HRQOL. Welsch et al. (2003) developed a model
for recognizing factors that affect quality of life in patients with Parkinson’s disease.
These factors include a multitude of measures that contribute to quality of life for those
with Parkinson’s disease, including physical function, mental/physical/emotional
wellbeing, self-image, health related distress, cognitive function, communication, sleep
and rest, eating, role function, energy/fatigue, and sexual function.
The Japanese Association of Patients with Parkinson’s Disease found that patient
education led to better HRQOL (Shimbo et al., 2004). In the Netherlands, researchers
concluded that Parkinson’ s disease patients who have autonomic dysfunctions, nighttime
sleep problems, and cognitive dysfunction are at risk for deterioration of HRQOL.
Of all the determinants contributing to HRQOL, depression is the strongest and
the most common factor associated with decreased HRQOL in patients with Parkinson’s
disease (Kadastik-Eerme et al., 2002). Feelings of hopelessness are common in those who
are clinically depressed (Abramson, Alloy, & Metalsky, 1989), and hopelessness
concerning the future is one the main characteristics of depression (Beck, Rush, Shaw, &
Emery, 1979). Therefore, having hope is pertinent to giving meaning and value to life;
the contrary, the loss of hope, has been found to decrease quality of life (Rustoen, 1995).
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Hope
Hope is a positive belief that allows people with chronic illnesses to overcome
devastating diseases and become survivors. Frankl, an Australian psychiatrist who spent
years as a prisoner in concentration camps during World War II, describes an example of
hope related to devastation. Frankl observed that if people lose hope, they do not live
long. He believed people with hope have meaning in their lives, but if they have no hope,
they have no meaning (Frankl, 1959).
In a study of 96 newly diagnosed cancer patients in Norway, hope was found to
be a coping strategy to enhance quality of life (Rustoen, 1995). Hope contributes
positively to health and is healing for those going through a period of stress or loss. A
hopeful mindset helps persons cope in order to attain higher quality of life (Farran, Herth,
& Popovich, 1995).
The concept of hope is essential for everyone, is applicable to all populations and
all areas of life, and is vital for those suffering with a debilitating chronic disease like
Parkinson’s. Nurses have the moral obligation to help their patients nurture hope when
faced with illness and disease (Simpson, 2004). Travelbee (1971) describes nursing as an
interactive process and notes hope is a future-oriented quality in which people look
forward to a time when life will be meaningful. Hope is a positive, joyful expectation that
something good is going to happen. In medicine, hope is essential to promoting health
and healing. By better understanding the function of hope in healing, nurses can help
restore their patients’ health.
Hope is often seen as an action (Green, 1977) and inspires persons to take action
to utilize health-promoting behaviors (Dufault & Martocchio, 1985). Participating in
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health-promoting behaviors for persons with cancer improves their quality of life. Cancer
survivors, compared to the public, do not participate in equal levels of exercise, eating
healthy, and maintaining a healthy weight (Meraviglia, Stuifbergen, Parsons, & Morgan,
2013). Nurses also must recognize the signs of hope and hopelessness in their patients’
actions, and respond accordingly.
Health-Promoting Behaviors
The social science of health promotion benefits the general public by teaching
people to make better health choices (Ruth, 2015). According to McCutcheon (2015),
health-promoting behaviors relate to the following sciences: biological, physical,
psychosocial, and environmental. The common goal is improving health. McCutcheon
described empowerment, participation, and community as attributes of health-promoting
behavior. McCutcheon concluded that health-promoting behaviors lack definition and
application in nursing literature.
Whitehead (2004) states nurses use terms like health promotion and health
education interchangeably and the focus of health promotion should be more on
community driven health reform, community empowerment, social objectives, and health
policy. He criticizes some nursing theories for using a health education model and calling
it health promotion.
Other nurse researchers have also scrutinized nursing literature on the
contextualization of the term health promotion. Kemppainen, Tossavainen, and Turunen
(2012) consider the focus of health promotion in nursing to be on disease prevention and
needs to be overhauled to a health promotion philosophy.
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A few researchers relate their definition of health promotion and health-promoting
behaviors back to the World Health Organization and the importance of exerting control
over health and health determinants to improve health (WHO, 2015). Polvsen and Borup
(2011) refer to health promotion as the combination as the social and political process to
regulate health determinants and improve health and quality of life. The College of Public
Health (2013) describe the improvement on individual, group, community and system
changes to improve overall knowledge, skills, attitudes and health behaviors.
Health-promoting behaviors are actions focused on developing levels of
wellbeing and realizing health potential on an individual level, within families and
communities, and throughout societies (Pender, 1987). Some examples of activities
utilized for health promotion for persons with Parkinson’s disease relate to healthy
eating/diet, physical activity/exercise, stress level, sleep, inner peace, and self-esteem
(Fowler, 1997).
Summary Hope, Health-Promoting Behaviors, and Health-Related Quality of Life
The perspective of a person with respect to hope, health promotion, and HRQOL
plays a pivotal role in engaging health-promoting behaviors for people with Parkinson’s
disease and patient outcomes. Hope is foundational to healing and can empower people to
choose health-promoting behaviors. Hope is related to action in empirical studies, and
this action can parallel health-promoting behaviors (Fowler, 1997). Fowler’s (1997) study
showed a positive relationship between hope and a health-promoting lifestyle in persons
with Parkinson’s disease who completed the Herth Hope Index (HHI) and HealthPromoting Lifestyle Profile II (HPLP II). The literature lacks further support on the
association between hope and health-promoting behaviors.
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The association between Parkinson’s disease and decreased HRQOL has been
studied extensively worldwide (Caap-Ahlgren & Lannerheim, 2002; Haahr, Kirkevold,
Hall, & Ostergaard, 2011; Leonardi et al., 2012; Miyashita et al., 20110; Post et al., 2011;
Qin et al, 2009; Visser et al., 2009; Weintraub, Moberg, Duda, Katz, & Stern, 2004;
Winter et al. 2010a, 2010b, 2011). However, there is limited research in the United
States (Welsch et al., 2003). This creates a gap in the literature, given that the United
States has the highest prevalence of Parkinson’s disease in the world. Knowledge gained
in this study will provide insight into ways to improve health, health-promoting
behaviors, and HRQOL for those with Parkinson’s disease. According to Pender,
Murdaugh, and Parsons (2015) the purpose of nursing research is to create knowledge to
enhance health. Enhancing health parallels easing the burden of disease.
Based on the literature by Fowler’s (1997) there is a positive relationship between
hope and a health-promoting lifestyle in persons with Parkinson’s disease who completed
the Herth Hope Index (HHI) and Health-Promoting Lifestyle Profile II (HPLP II) but the
literature lacks further support on the association between hope and health-promoting
behaviors. Hope interventions have improved quality of life in persons with cancer
(Herth, 2000). The literature shows that health-promoting behaviors in a variety of
populations including persons with breast cancer, HIV, multiple sclerosis, polio, and
Parkinson’s disease all relate to high levels of hope (Bouchard, 1992; Fowler, 1997; &
Harrison, 1993).
The effect hope and health-promoting behaviors play on HRQOL is critical
because health is so much more than absence of disease. For persons with Parkinson’s
disease and others with a chronic illness, health must be seen alongside a continuum with
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disease. The severity of illness in Parkinson’s disease severely decreases HRQOL
(Global Parkinson’s Disease Survey Steering Committee, 2002). Initiating hope and
health-promoting behaviors can lessen the downward progression of the disease. By
having stronger levels of hope and health-promoting behaviors, persons with Parkinson’s
disease will be better equipped to manage as their disease progresses and maintain their
level of health, despite disease.
Purpose of the Study
The purpose of this study is to examine the relationship between the concepts of
hope, health-promoting behaviors, and HRQOL in people with Parkinson’s disease. The
hypothesis is a stronger level of hope and health-promoting behaviors will correspond to
a higher HRQOL, modifying for disease severity and progression.
The aims of this study are as follows: (1) to conduct a comprehensive exploration of the
relationships among hope, health-promoting behaviors, and HRQOL; (2) to test for a
moderating effect of hope on the relationship between health-promoting behaviors and
HRQOL; and (3) to explore the effect of disease severity on the relationship among hope,
health-promoting behaviors, and HRQOL.
Research Questions
1. What is the level of hope in persons with Parkinson’s disease?
2. What is the relationship between hope and health-promoting behaviors on HRQOL in
persons with Parkinson’s disease?
3. What is the relationship among hope, health-promoting behaviors, HRQOL, and
disease severity?
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Health-Promoting
Behaviors
Measured with HealthPromoting Lifestyle Profile
(HPLP II)
Higher HRQOL

H1 +
H3 +

H2 +

Measured with
Parkinson’s Disease
Questionnaire (PDQ8)

STRONGER HOPE
Measured with Herth
Hope Index (HHI)

Figure 1. Study framework.

Research Hypotheses
Three hypotheses are tested following the study framework. The first hypothesis
(H1+) predicts that persons with Parkinson’s disease have hope. The second hypothesis
(H2+) predicts that health-promoting behaviors will correspond to a stronger measure of
hope, which signifies a positive relationship between hope and health promoting
behaviors. Health-promoting behaviors and stronger level of hope are expected to lead to
a positive impact on HRQOL. The final hypothesis (H3+) proposed that higher levels of
hope and health promoting behaviors will correspond with higher HRQOL, modifying for
disease severity and progression which is measured by the patient’s self-report in the
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Hoehn and Yahr scale (see Appendix B).
Significance of the Study and Nursing Perspective
Some of the overarching goals of Healthy People 2020 include increasing the
years of healthy life and the quality of life for all Americans (U.S. Department of Health
and Human Services, 2012). Nurses can contribute to the future of healthcare by
promoting health for those who suffer from Parkinson’s disease and other debilitating
diseases. This goal is especially important in later stages of Parkinson’s disease when
medical treatment and medication no longer help fight the disease, and the focus of
treatment is to improve quality of life. An increase in the number of people with
Parkinson’s disease will require an increased number of nurses to care for them. Nurses
have an opportunity to help people cope with the wide variation of challenges from this
incurable lifelong disease. Race, education, and income are significant and independent
factors when determining the level of disability for Parkinson’s disease patients.
Researchers found health disparities in patients with Parkinson’s disease who are both
African American and lower income. African Americans and those with lower
socioeconomic status had progressed disease and further disability in disease
management upon seeking treatment. These disparities lead to earlier loss of
independence (“Parkinson’s Disparities,” 2010).
A better understanding of the relationship among hope, health-promoting
behaviors, and HRQOL will help nurses, patients, and caregivers promote a potential
hope intervention and encourage health-promoting behaviors for those with Parkinson’s
disease. Attributes of hope can increase coping mechanisms, which lead to improved
quality of life. Nurses play a significant role in influencing hope and, therefore, quality of
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life (Herth, 2000).
Although the connection between hope and quality of life has been studied in
people with cancer, it has not been studied in people with Parkinson’s disease. Herth
(2000) established that quality of life improves in cancer patients who receive hope
intervention, and Pender (1987, p.4) noted that one of the national health professional
goals is to promote health for those persons with chronic diseases or disability. Although
health-promoting behaviors and hope have been studied frequently in persons with
chronic illnesses, the literature reveals that this relationship was examined once in
persons with Parkinson’s disease (Fowler, 1997). Nurses are the leading section of health
professionals; therefore, they have the opportunity to uphold national health promotion
goals. Supporting a culture of health promotion is a significant role of nurses (Savage &
Kub, 2009).
Another significant role for nurses is to encourage hope. Watson’s Caring Model,
written in 1988, describes instilling hope as part of the second carative factor of nursing
(Watson, 2012). Nurses can integrate hope into their plan when caring for their patients.
Nurses can also encourage patients to practice health-promoting behaviors influencing
their overall health outcomes. Notably, by promoting health behaviors and encouraging
hope, nurses show they value the HRQOL of persons with Parkinson’s disease in all
settings. Enhancing hope for patients with Parkinson’s disease will, in turn, improve
HRQOL and human dignity for those struggling with this disease.
Definitions
Theoretical Definition Hope. A multidimensional energy, always present and
changing, which is described by a positive, yet unclear belief of reaching a future benefit
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(Dufault & Martocchio, 1985, p. 380). Hope is an individualized future orientated
experience that offers possibility and optimism despite uncertainty.
Operational Definition Hope. Hope is always changing, particularly when
overcoming life events such as chronic illnesses like Parkinson’s disease or aging. In this
study, hope is determined by a measurement at a point in time on the Herth Hope Index
(HHI) scale.
Theoretical Definition Health-Related Quality of Life (HRQOL). HRQOL
relates to an individual’s perception of their well-being related to disease and health
status (Winter, 2010a). Dignity has also been noted as a fundamental component of
quality of life (Manthorpe et al., 2010). In this study, quality of life is limited to HRQOL,
which has many facets. The focus is on the following domains related to Parkinson’s
disease: “mobility, activities of daily living, emotional well-being, stigma, social support,
cognition, communication and bodily discomfort,” (Rodriguez-Violante et al., 2013,
p.11).
Operational Definition Health-Related Quality of Life (HRQOL). In this
study the Parkinson’s Disease Questionnaire-8 item version (PDQ-8) will measure
HRQOL and specifically the domains of “mobility, activities of daily living, emotional
well-being, stigma, social support, cognition, communication and bodily discomfort,”
(Rodriguez-Violante et al., 2013, p.11).
Theoretical Definition Health-Promoting Behaviors. The World Health
Organization (WHO, 2015) defines health promotion as “the process of enabling people
to increase control over their health and its determinants, and thereby improve their
health.” Health-promoting behaviors relate to “activities directed toward increasing the

14
level of well-being and actualizing the health potential of individuals, families,
communities and societies” (Pender et al., 2015, p. 4).
Operational Definition Health-Promoting Behaviors. In this study, healthpromoting behaviors will be measured using Pender’s Health-Promoting Lifestyle Profile
II (HPLP- II). The scale for HPLP-II measures self-actualization, health responsibility,
exercise, nutrition, interpersonal support, and stress management (Walker, Sechrist, &
Pender, 1987).
Theoretical Definition Parkinson’s Disease. Nearly 200 years ago, Dr. James
Parkinson of London noted a phenomenon he called the shaking palsy. The first
characteristic he noted included a tremor at rest, stooped posture, and a shuffling gait
(Parkinson, 1817). Three classic signs of the disease are tremor at rest, rigidity, and
slowness. Two of these three clinical manifestations are necessary for diagnosis
(Bunting-Perry & Vernon, 2007).
Operational Definition Parkinson’s Disease. Parkinson’s disease is a chronic
progressive neurological disease with motor, non-motor, and neuropsychiatric symptoms,
which mainly effects the elderly. Parkinson’s disease is characterized by a loss of
dopamine in the brain (Bunting-Perry & Vernon, 2007).
Theoretical Definition Disease Severity. Disease severity indicates the amount
of disease in the body. In Parkinson’s disease the greater the amount of motor disability
leads to greater disease severity. Disease severity does not indicate disease progression, it
is only the statement of where the patient is rated at the current time (Bunting-Perry &
Vernon, 2007).
Operational Definition Disease Severity. Hoehn and Yahr (H&Y) staging
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measures the disease severity of Parkinson’s disease in the study. The mildest stage with
unilateral symptoms is H&Y 1. A wheelchair-bound or bed-ridden state is the most
severe stage, which is H&Y 5 (Hoehn & Yahr, 1967).
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CHAPTER 2: REVIEW OF LITERATURE
Introduction
The purpose of this study is to describe the relationship between hope, healthpromoting behaviors, and quality of life in people with Parkinson’s disease. The critical
literature review provides a foundation for examining this relationship. The literature
review begins with an examination of both the prevalence and health consequences of
Parkinson’s disease. It synthesizes findings on the concepts of hope, health-promoting
behaviors, and health-related quality of life (HRQOL). Literature was reviewed by
concepts and in phases. The theoretical framework guiding the study is also described.
Prevalence of and Health Cost Related to Parkinson’s Disease
As the number of persons with Parkinson’s disease grows the costs of treating
them also increases. The economic impact of Parkinson’s disease is an estimated $25
billion per year in the United States (PDF, 2016). The financial burden for Parkinson’s
disease patients combines direct costs and indirect costs of the disease, such as treatment,
social security payments, lost income from work, and homecare. Medications alone cost
an individual with Parkinson’s disease $2,500 a year, and therapeutic surgeries can cost
around $100,000 dollars per patient (PDF, 2016).
The highest prevalence of the disease in the United States is in Nebraska,
followed by South Dakota (CDC, 2015). The heartland of America is well known for
farming communities that heavily use insecticides and pesticides. Studies have noted the
occupational risks of farming associated with Parkinson’s disease, illustrating that the
risk of Parkinson’s disease rises with exposure to pesticides --(Kenborg, Lassen, Lander,
& Olsen, 2012; Wright Willis, Evanoff, Lian, Criswell, & Racette, 2010). Common
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pesticides are neurotoxic and can trigger changes in the brain that are similar to the loss
of neurons in the brain and other pathological features that cause idiopathic Parkinson’s
disease (Allen & Levy, 2013).
The Agriculture Health Study also suggests that contact with pesticides increases
the danger of Parkinson’s disease (Kamel et al., 2007). The study initially compared
79,557 persons who applied pesticides in relation to self-reported Parkinson’s disease.
Applying the chemical paraquat was associated with 87 prevalent cases of Parkinson’s
disease. The odds ratio for the incidence of Parkinson’s disease for those that applied
chemical compared to the cohort control was 2.3%, confidence interval: 1.2, 4.5, and p =
.0009. The study noted that certain chemicals may increase Parkinson’s disease risk, a
premise that needs further investigation. A limitation of the study was the dependence on
self-reporting of disease.
A Danish study of gardeners exposed to pesticides concluded that an association
between a small-dose exposure to pesticides and the risk for Parkinson’s disease could
not be ruled out (Kenborg et al., 2012). The study of 3,124 male members of the Danish
Union of Gardeners indicated a weak but dose-related association of pesticide exposure
and diagnosis of Parkinson’s disease using hospital-registered data (Kenborg et al.,
2012).
A number of studies over the past 25 years suggest well water contaminated with
agricultural pesticides play a role in the etiology of Parkinson’s disease (Gatto et al.,
2009; Marder et al., 1998; Morano et al., 1994; Smargiassi et al., 1998; Wang, Fang,
Cheng, Jiang, & Lin, 1993; Wechsler et al., 1991; Wong et al., 1991). Several of these
reports were small, less than 100 cases and all were self-reported exposure to pesticides.
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Gatto, Cockburn, Bronstein, Manthripragada, & Ritz (2009) found consuming
well water contaminated by agricultural pesticides increases the relative risk of
Parkinson’s disease. This study took place between 2001 and 2007 in Central Valley
California, which is well known for its high agricultural activities. This study did not rely
on self-reporting, but sampled the water for six different pesticides and compared to
documented data. They completed a geographic system of controls and found 368 cases
with Parkinson’s disease had consumed private well water 4.3 years longer than the 341
controls enrolled in their study. The study supports consuming well water contaminated
with pesticides has an associated risk of Parkinson’s disease.
Summary
As the population ages, the number of persons with Parkinson’s disease increases,
and so does the financial burden of the disease (Achey et al., 2014). The financial loss
and burden of Parkinson’s disease in cost of medicines and treatments does not compare
to the emotional loss and suffering from disease. The growing number of persons with
Parkinson’s disease is concerning, especially in the agricultural heartland of America
where the disease prevalence and risk for the disease is already high compared to other
areas of the United States (CDC, 2015; Kamel et al., 2007; PDF, 2016).
Hope
The key literature search for hope examined literature from the EBSCOhost
database (incorporating the following databases CINAHL, MEDLINE, and PsychINFO).
The years were limited from 2000 to 2017. Next, the search for terms hope and nursing
were combined. Nursing was added to the search to decrease the number of articles,
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which was focused on hope for a cure or hope for stem cells in Parkinson’s disease.
Pertinent literature from earlier years was also included in the literature review.
Hope first appeared in healthcare literature in the mid-1960s with a focus on
spirituality (Lynch, 1965). Since then, many researchers have redefined hope. According
to Erickson (1964), hope is part of the developmental process as the first stage of
development, an outcome of basic trust versus mistrust, which is the basis for
experiencing security with an attachment figure. The quality of the attachment experience
contributes to later experiences of either hope or despair. An infant or young child’s
attachment to a parental figure provides a foundation that can either encourage the child
to hope or to despair. A good role model of hope can have a positive effect on a child’s
development; even in situations promoting negative effects of home, however, an
individual can choose to overcome any trust barriers developed in childhood to
potentially yield an outcome of hope. Further studies showed that hope had a positive
correlation with social support (Edwards, Ong, & Lopez, 2007; Heaven & Ciarrochi,
2007; Mahat, Scoloveno, & Whelan, 2002; Yarcheski, Mahon & Yarcheski, 2001; Vacet
et al., 2010).
Critical literature on hope was identified by a concept analysis building on the
work of Dufault and Martocchio (1985) who described hope in persons with cancer.
Hope has two spheres: (1) generalized hope, where the end result is desired; and (2)
particularized hope, which relates more to meaning in life. The two spheres can overlap.
There are six dimensions of hope depicting experiences related to “affective, cognitive,
behavioral, affiliative, temporal, and contextual” domains (Dufault & Martocchio, 1985,
p. 381). Health practices, self-care agency, and health-promoting factors are positive
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outcomes of hope and are consistent with Dufault and Martocchio’s conceptualization of
hope (Canty-Mitchell, 2001; Mahat & Scoloveno, 2001; Mahat et al., 2002; Mahon et al.,
2004).
Hope differs depending on the environment, and hope changes when illness
strikes. The different attributes that enable people to hope allow hope to be a unique and
ever-changing process. Several patterns in the language describing hope were identified.
Concepts that appeared repeatedly were as follows: hope is future orientated, requires
energy, is goal orientated, and contains an element of uncertainty (Amendolia, 2010;
Dorcy, 2010; Lohne & Severinsson, 2004). Other terms related to hope that appeared in
the literature were power, realism, meaningful, internal, intuitive, integrative, holistic,
anticipation, realism, and essential for life (Amendolia, 2010; Dorcy, 2010).
Duggleby et al. (2010) examined hope in 20 studies from a variety of countries in
persons with different medical diagnoses. The authors described hope as being dynamic
and future orientated, as well as being able to transcend possibilities and involve choice.
Older and younger persons differed in their interactions with hope when suffering, but
regardless of age, the 20 studies emphasized the importance of incorporating strategies to
help those with chronic illness sustain hope.
For those afflicted with Parkinson’s disease, the literature mentions a significant
loss of self-esteem, which correlates to the need to promote hope, a health-promoting
behavior, to improve self-esteem. Hope occurs when people have high self-esteem
(Cantrell & Lupinacci, 2004; Heaven & Ciarrochi, 2007; Ritchie, 2001; Simon, Barakat,
Patterson & Dampier, 2009; Vacek et al., 2010). Additionally, life satisfaction has a
positive and statistically significant correlation with hope (Bronk, Hill, Lapsey, Talib &
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Finch, 2007; Gilman, Dooley, & Florell, 2006; Hexdall & Huebner, 2007; Shoegren et
al., 2006; Vacek et al., 2010; Valle et al., 2006; Wong & Lim, 2009).
Empirical studies suggest that religious values help with coping and have an
association with increased hope. Heaven & Ciarrochi (2007) studied 784 participants and
found participants who had higher religious values also had higher levels of hope. Miller
and Kelly (2005) also found an elevated level of hope and optimism in persons with
religious values. Their study linked religion to better mental health and having more hope
improved coping mechanisms. Another study of 126 low socioeconomic minorities
reported that having hope directly relates to religious coping. This study examined diaries
of adolescents and discovered having hope helped buffer stress (Roesch, Duangado,
Vaughn, Aldridge, & Villodas, 2010).
Hope is a construct that studies have shown to improve coping in multiple
populations such as the elderly, those with cancer, spinal cord injury, mental illness, heart
disease, and stroke (Bland & Darlington, 2002; Bluvol & Ford-Gilboe, 2004; Herth,
1993; Farran et al., 1995; Lohne & Severinsson, 2004). Hope improves coping skills and
adaptation capacities and does not decrease as age increases (Lieberman and Tobin,
1983). In the elderly population, literature shows hope is an essential human need
(Forbes, 1994).
Herth studied hope in 125 patients with recurrent cancer receiving treatment. The
study was a quasi-experimental design with three groups. The first group received a hope
intervention, the second group was an informational control group that received and the
last group was a group that received no information other than regular hospital care. At
the start of the study, the level of hope was low for all groups compared to other cancer
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patients (Rustoen, 1998; Herth, 1990, Herth, 2000). A significant difference in the level
of hope was found in the cancer patients related to level of energy, sleep, and concurrent
losses. The hope score decreased slightly for all groups at three months. However, the
hope control group did have significant higher mean hope score than the informational
group (P=0.034) and the control group (P=0.015). The hope scores also decreased at six
and nine months for the all groups, but the mean hope score for the hope intervention
group remained higher than the attention group (P=0.032) and the control group
(P=0.025) (Herth, 2000).
Summary of Hope
Hope is thought to originate from the first stage of psychosocial development
(Erickson, 1964). The two main spheres of hope are generalized hope and particularized
hope with six domains: affective, cognitive, behavioral, affiliative, temporal, and
contextual (Dufault & Martocchio, 1985) Hope occurs during chronic illnesses and
promotes the healing process (Farran, Herth, & Popovich, 1995). Hope has been studied
largely in populations with cancer (Dufault & Martocchio, 1985; Rustoen, 1995; Herth,
1989), in populations with chronic diseases (Duggleby et al., 2010; Lohne & Severinsson,
2004), and in healthy populations (Farran et al., 1990; Forbes, 1994). Three of the main
attributes of hope are that it is future orientated, requires energy, and is goal orientated
(Amendolia, 2010; Dorcy, 2010; Duggleby et al., 2010; Lohne & Severinsson, 2004).
Health-Related Quality of Life
The literature search on quality of life surveyed literature from the EBSCOhost
database (incorporating the following databases CINAHL, MEDLINE, and PsychINFO).
The search was narrowed to full text and peer-reviewed articles from 2000 to 2017.

23
Articles specifically related to the concept of HRQOL were examined. The literature was
researched using the terms hope and quality of life together. However, when limiting this
process further by adding the term Parkinson’s disease, no articles were found. Thus, the
literature did not address the levels of hope and quality of life in persons with Parkinson’s
disease.
Quality of life it is an abstract idea with numerous meanings and with several
conceptual definitions. Quality of life relates to culture, values, goals, and expectations
HRQOL specifically relates to physical health and mental health (CDC, 2015). The
literature discusses HRQOL and Parkinson’s disease in a number of European studies,
which are reviewed below.
Winter et al. (2010a, 2010b, 2011) completed a sequence of studies in Europe
examining HRQOL in Parkinson’s disease. The first study in Austria assessed HRQOL in
100 persons with Parkinson’s disease and found the HRQOL score was lower than the
general population (Winter et al., 2010a). Scores related to mobility and pain were high,
leading to a decrease in HRQOL. Age, depression, motor fluctuations, and disease
severity were the main determinants of HRQOL. Overall, the Winter et al., (2010a) study
promoted social support and home care for persons with Parkinson’s disease to improve
their HRQOL.
Similarly, a study in Russia investigated the HRQOL in persons with Parkinson’s
disease. Winter et al. (2010b) noted that Parkinson’s disease affects the vulnerable
population of the elderly. Their study recognized the importance of assessing HRQOL in
this population in order to provide better healthcare programs for the more vulnerable. In
a sample size of 100 persons with Parkinson’s disease, 98% of participants had moderate
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or severe scores in mobility, pain, and anxiety. The control group had 74%, which is a
significantly lower HRQOL score in these problem areas (Winter et al., 2010b).
The last study in the series took place in Italy, where HRQOL in Parkinson’s
disease showed mobility, pain, and anxiety as common dimensions reducing HRQOL
(Winter et al., 2011). Other determinants that reduced HRQOL scores were increased
disease severity, depression, and dementia. The results encouraged the national
healthcare programs to focus on education and social support in order to improve
HRQOL related to motor and non-motor symptoms (Winter et al., 2011).
The prevalence of non-motor symptoms in Parkinson’s disease leads to increased
disability and is associated with decreased HRQOL (Leonardi et al., 2012; Post et al.,
2011; Weintraub, Moberg, Duda, Katz, & Stern, 2004;). Studies found non-motor
symptoms associated with decreased HRQOL more than motor symptoms. For example,
Rodriguez-Violante et al. (2013) identified clinical and demographic factors of HRQOL
and anticipated decreased HRQOL among patients with advanced Parkinson’s disease.
The study included 177 patients with Parkinson’s disease in Mexico City. The study
evaluated patients using several scales, one of which was the Parkinson’s Disease
Questionnaire (PDQ-39) that measures quality of life of persons with Parkinson’s
disease. The researchers did not find an association between HRQOL and dyskinesia.
Specifically, neuropsychiatric features of the disease were more problematic and
associated with higher scores on the PDQ-39, which is associated with lower levels of
HRQOL (Rodriguez-Violante et al., 2013).
Qin et al. (2009) determined the non-motor symptoms of depression, sleep
disorders, and fatigue attributed to 61.7% of the variance of HRQOL in 391 Chinese
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patients with Parkinson’s disease. Motor and non-motor symptoms were measured by
multiple regression analyses to determine which variables were associated with HRQOL.
The study found that HRQOL improves only if support is provided for all aspects of
Parkinson’s disease, and not just motor symptoms.
Miyashita et al. (2011) reported all the domain of quality of life of patients with
Parkinson’s disease in Japan was significantly lower than in the general population.
Questionnaires were sent to 1,577 persons with neurological diseases, and of the 785 who
responded, 273 had Parkinson’s disease. The study explored the correlation between
quality of life for patients and caregivers. When depression was present in patients, there
was a significant reduction on quality of life for caregivers. Patients who had decreased
physical function correlated with an increase in care burden and a decrease in caregiver’s
quality of life.
A study in the Netherlands showed that worsening psychosocial well-being,
mood, and cognitive function over a two-year period was associated with decreased
HRQOL (Visser et al., 2009). Visser et al. (2009) examined 336 patients longitudinally
over a two-year period, revealing that patients who have autonomic dysfunctions,
nighttime sleep problems, and cognitive dysfunction are at risk for deterioration of
HRQOL.
Researchers in Scandinavian countries examined quality of life in persons with
Parkinson’s disease. According to a Swedish study, Parkinson’s disease affects not only
the quality of life of the individual, but also of the family. Furthermore, the study showed
that not knowing when to expect impaired mobility leads to frustration and social
withdrawal in patients (Caap-Ahlgren & Lannerheim, 2002). Parkinson’s disease
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threatens a person’s ability to maintain family and social contacts, which leads to
decreased independence (Welsch et al., 2003). Researchers in Denmark explored how
living with Parkinson’s disease leads to a loss of independence and self-esteem (Haahr,
Kirkevold, Hall, & Ostergaard, 2011).
The Global Parkinson’s Disease Survey (2002) examined quality of life in 31
Parkinson’s disease patients in an outpatient geriatric center in Sweden and reported
disease severity as a significant predictor for HRQOL. The study showed increasing
problems as the disease progressed. Even before the disease reached advanced stages,
quality of life was affected.
Findley (2002) surveyed people from six countries with Parkinson’s disease and
discovered depression is significantly associated with quality of life. Findley’s (2002)
international study of 1,190 patients in six countries associated depression significantly
with quality of life. Over 50% of patients had a score above 10 on the Beck Depression
Inventory, indicating mild depression. However, this result was not reflected in the
patient’s self-assessments, as only one percent of the patients evaluated themselves as
depressed.
Gage, Hendricks, Zhang, and Kazis (2003) found that veterans with Parkinson’s
disease had lower scores on mental and physical health scales compared to veterans with
other conditions, such as heart disease, congestive heart failure, stroke, diabetes, arthritis,
or lower back pain. This is a problem because, as the population ages, the number of
persons with Parkinson’s disease is expected to increase (Welsh et al., 2003), and this
chronic progressive disease of late adulthood has no cure yet.
It is important for the healthcare professionals to focus on patients’ perceptions of
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quality of life and develop strategies for improving daily life for those patients (Wressle,
Bringer, & Granerus, 2006). In contrast to acute diseases wherein a cure is the ultimate
goal, the goal of treating Parkinson’s disease is to minimize symptoms and improve
HRQOL. A study using 1,200 randomly selected participants from the Japanese
Association of Patients with Parkinson ’s Disease showed that patient education led to
better HRQOL (Shimbo et al., 2004).
Winter et al. (2010a, 2010b, 2011) discussed an average of over 80% of patients
with Parkinson’s disease patients are dependent on cares mostly provided by family
members. This high number of persons depends on others to help them with their ADLs
because of their disease severity. Lou (2015) describes as severity of illness increases;
fatigue severity also increases leading to decreased HRQOL. Fatigue is associated with
several of the non-motor symptoms of Parkinson’s including apathy, sleep disorders,
cognitive dysfunction and depression.
Problems with mobility, anxiety, depression, and pain are common problems
decreasing HRQOL in persons with Parkinson’s disease (Winter et al., 2011). These
problems could classify as possible barriers for using this model. Few studies have
recognized the effect of depression in Parkinson’s disease. However, the impact
depression has on HRQOL is important to recognize as depression is clearly associated
with lower HRQOL and health-promoting behaviors (Dowding, Shenton & Salek, 2006;
Jones, Pohar, & Patten, 2009; Schrag, 2006). Withdrawing from social life is another
possible barrier that could result in lower HRQOL for persons with Parkinson’s disease.
Summary of Health-Related Quality of Life
The conceptual meaning of HRQOL includes the following domains: physical
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functioning, role physical, bodily pain, general health perceptions, vitality, social
functioning, role emotional, and mental health (Sigstad et al., 2005). Fourteen studies that
examined HRQOL in Parkinson’s disease were reviewed. The main determinants of
HRQOL were age, depression, motor fluctuations, and disease severity (Winter et al.,
2010a). HRQOL is important to assess in persons with Parkinson’s disease because they
are a vulnerable population (Winter et al., 2010a). This leads to an opportunity to provide
better healthcare programs for those who are vulnerable.
Health-Promoting Behaviors
The literature search on health-promoting behaviors examined literature from the
EBSCOhost database (incorporating the following databases CINAHL, MEDLINE, and
PsychINFO). The search was limited to peer reviewed journals published between 2000
and 2017. Abstracts were reviewed for relevancy to nursing.
Tengland (2010) defined health promotion beginning as a public health belief and
emphasizing a holistic model promoting social and economic determinants of health at a
population level as well as focusing on vulnerable groups and inequality. Trembley and
Richard (2011) relate health promotion to the individual, group, or community level and
use a variety of approaches to improve health at an individual and environmental level.
Glanz and Maddock (2002) describe health-promoting behaviors as the activities
of multiple levels that correlate with change and policy development as a result of these
activities. A big outcome of the changes brought about by health-promoting behavior is
an improvement in coping skills and quality of life.
Liu et al. (2009) studied women in Taiwan who had an abnormal papanicolaou
test. This study had a convenience sample of 101 rural women and 14% of these women
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had precancerous results. In their study, they defined health-promoting behaviors in
women’s health related to three aspects: health responsibility, stress management, and
exercise. The researchers developed interventions to help women with positive
papanicolaou results select treatment options and implement healthy behaviors.
Pender (1987) developed one of the predominant health-promotion models to
describe health-promoting behaviors. This model has been published extensively within
the literature and is commonly used in nursing practice (King, 1994). One strength of the
health-promotion model is the scale, the Health-Promoting Lifestyle Profile (HPLP),
which measures self-actualization, health responsibility, exercise, nutrition, interpersonal
support, and stress management (Walker, Sechrist, & Pender, 1987). The model stresses
cognitive influences on health, personal decision-making, individual control, and
individual definition of health (Whitehead, 2001).
The health-promotion model by Pender works well for preventative, behavioral,
health-related concepts, and disease-centered concepts (Whitehead, 2001). Stuifbergen
and Rogers (1997) validated this model when they examined health-promotion behaviors
related to quality of life for those with chronic conditions.
Bouchard (1992) used Pender’s framework and studied health-promoting
behaviors and hope in a population of 76 persons with breast cancer. Bouchard found
hope correlates significantly with several items from the HPLP questionnaire. Hope has a
strong relationship with health-promoting behaviors (p=0.001), health responsibility
(r=.396), stress management (r=.396), interpersonal relations (r=.396), and selfactualization (r=.624).
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For the purpose of this research, health-promoting behaviors relate to Pender’s
(2015) definition relating to increasing health potential and well-being at multiple levels,
which include individual, family, community, and society. Numerous researchers have
used Pender’s definition of health-promoting behaviors to help individuals achieve wellbeing and improve health.
Fowler (1997) discussed hope and health-promoting behaviors in persons with
Parkinson’s disease. The sample consisted of 42 patients with Parkinson’s disease who
completed the HHI and HPLP II. The study showed a moderate positive relationship
between hope and a health-promoting lifestyle (r=.40, p=.008). Significant correlations
related to hope were health-promoting lifestyle, spiritual growth, and interpersonal
relations. Findings showed women had a higher mean score in physical activity than
males (t=-2.28, p=0.03). Adults with Parkinson’s disease had a low level of physical
activity compared to the general population. Even though the population of this study has
a progressive debilitating disease, they were involved in health-promoting behaviors and
were considered hopeful.
Stuifbergen (1995) found similar results in her study with 61 women with
multiple sclerosis. In this descriptive correlational study, she noted a strong correlation
between health-promoting behaviors and quality of life. Health-promoting behavior
subscales of physical activity and nutrition on the HPLP II correlated significantly with
objective measures of activity and nutrition. Low level of activity in persons with this
chronic disease may be seen when persons do not over exert due to fatigue, which starts a
cycle of inactivity resulting in loss of balance, muscle weakness, depression, sleep
problems, and cardiovascular deficits. Thus promoting physical activity is essential, in

31
not only women with multiple sclerosis, but also the general population.
Stuifbergen and Roberts (2005) also surveyed health-promoting behaviors and
quality of life in a convenience sample of 629 women with multiple sclerosis. In this
sample, women also scored lower on the physical activity and spirituality subscale
compared to other groups. The method of the study was descriptive correlational and the
data collection was cross sectional. Health-promoting behaviors in this sample
contributed to quality of life. Behaviors such as eating healthy, exercise, and stress
management influence the response to physical deterioration associated with multiple
sclerosis and other chronic disabling conditions.
Stuifbergen, Seraphine, Harrison and Adachi (2004) demonstrated that healthpromoting behavior variables are similar in another chronic neurological condition, postpolio syndrome. This study had a descriptive correlational design and the sample was a
large convenience sample of 2153 persons with post-polios syndrome. The path
coefficient in the multiple sclerosis study and the post-polio study were almost equal in
the samples (multiple sclerosis =0.17 and post-polio=0.19). The relationship implies
health-promoting behaviors increase quality of life.
Harrison (1993) examined hope, perceived health status and health-promoting
lifestyle in persons with HIV. An item of Pender’s scale includes optimism, a dimension
of health expression, which in this study Harrison identified optimism as hope. Harrison
found a positive correlation between a health-promoting lifestyle and hope (r=.64,
p<.001). Hope was entered into a hierarchal multiple regression of accounted for 41.4%
of the variance. Hope had a strong correlation with self-actualization (r=.78, p<.001),
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moderately high with interpersonal relationships (r=.78, p.001) and interpersonal support
(r=.55, p<.001). Hope had a low correlation with stress management (r=.39, p<.001).
Self-efficacy has been associated with health-promoting behaviors for not only
persons with chronic disabling conditions, but for all persons (Strecher, DeVellis, Becker,
Rosenstock, 1986; Stuifbergen & Becker, 1994). Self-efficacy allows persons with
Parkinson’s disease to be resilient and is essential to cope with chronic illness (Nelson,
Wong & Lai, 2011). Patients with a variety of chronic conditions were better able to
manage their symptoms and utilize health care services when they had perceived high
levels of self-efficacy (Lorig et al., 1999).
Summary of Health Promotion
The literature described multiple definitions of health-promoting behaviors in
persons in a variety of populations including cancer, HIV, and chronic neurological
conditions such as polio, multiple sclerosis, and Parkinson’s disease. These persons were
described to have health-promoting behaviors related to their high level of hope
(Bouchard, 1992; Fowler, 1997; & Harrison, 1993).
Summary of Gaps in the Literature
The state of the science shows an association between Parkinson’s disease and
decreased HRQOL. The literature suggests that HRQOL decreases when non-motor
symptoms increase disability (Leonardi et al., 2012; Post et al., 2011; Weintraub,
Moberg, Duda, Katz, & Stern, 2004). The major non-motor symptom associated with
decreased HRQOL is depression, which is a common factor in Parkinson’s disease
(Kadastik-Eerme et al., 2002). The literature also established an association between hope
and quality of life. Herth (2000) noted that quality of life improves in cancer patients who
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received a hope intervention. The literature describes hope as an essential component for
improving quality of life in cancer patients (Rusteon, 1995; Herth, 1990, 2000). This
connection has not been established in people with Parkinson’s disease.
Limited research has been completed related to these variables in people with
Parkinson’s disease. Hope has been studied in healthy persons and persons with chronic
illness, but not significantly in persons with Parkinson’s disease. Fowler (1997) examined
the relationship with hope and health-promoting behaviors in persons with Parkinson’s
disease and found a positive relationship between hope and health-promoting behaviors.
The presence of all three concepts together is not evident in the literature and only
Fowler’s article was noted with two of the concepts, thus there is a need for more current
research, which creates a need for more studies. These three concepts of hope, healthpromoting behaviors, and health-related quality of life have not been studied in persons
with Parkinson’s disease. This is significant given that the Midwest has the highest
prevalence of Parkinson’s disease in the world. Expanded knowledge from this study will
offer understanding into means to improve health-promoting behaviors, hope, and
HRQOL for those with Parkinson’s disease.
Theoretical Frameworks
The conceptual framework for this study is based on Stuifbergen & Roger’s
(1997) Explanatory Model for Health-Promotion within Chronic Conditions. The model
is well tested and incorporates concepts from Pender’s (1987) Health-Promotion Model
(HPM) and Bandura’s Social Cognitive Theory (1986). The concepts from Pender and
Bandura are the backbone for Stuifbergen’s theory.
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Development of Explanatory Model of Health-Promoting Behaviors within Chronic
Conditions
Pender’s Health Promotion Model. Stuifbergen’s Explanatory Model of HealthPromoting Behaviors within Chronic Conditions is based on the HPM, a theoretical
framework describing relationships that contribute to a health-promoting lifestyle.
Initially Pender (1987) developed the HPM as a framework that serves as a guide for
predicting behaviors. The HPM is helpful in investigating different factors that influence
a person’s ability to perform health-promoting behaviors. Behaviors include selfactualization, health responsibility, physical activity, nutrition, spirituality, interpersonal
support, and stress management (Pender, 1996).
Marriner- Tomey & Alligood (2010) describe the concepts of Pender’s HPM as
follows: Behaviors that relate to prior behavior have an influence on current healthpromoting behaviors. Personal factors such as biological, psychological, and
sociocultural factors also influence current health-promoting behaviors. The perceived
benefits of action equal the benefits of getting on board with the health activities.
Perceived barrier are problems like lack of money, which could delay health-promotion
activities. Perceived self-efficacy is a strength to persevere and meet goals attributing to
health promoting behaviors. Activity related affect is an interchange of activities not
related to health-promotion activities. Interpersonal influences include different
relationships that Situational influences prepare the individual for or steer them away
from participating in health-promoting activities. Commitment to a plan of action
summarizes steps to take health promotion tactics. Immediate competing demands and
preferences include any part of the individual’s life that interferes with accomplishing
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health-promoting behaviors. Anything that causes a favorable health outcome is
considered a health-promoting behavior (Marriner-Tomey & Alligood, p. 438-439.
2010).
Social Cognitive Theory (SCT). Self-efficacy undergirds Stuifbergen’s model
and was first introduced as a major assumption of Bandura’s SCT. Bandura (1997)
describes self-efficacy to be a person’s belief about their abilities to control their own
behavior and events affecting their lives. Self-efficacy plays a role in decreasing stress
and improving coping through a person’s self-appraisal of coping abilities necessary to
deal with a stressful event (Bandura, 1989; Benight & Bandura, 2004). Self-efficacy is
needed to maintain social and coping skills required for chronic disease management.
Explanatory Model of Health Promotion and Quality of Life in Chronic Disabling
Conditions
The Explanatory Model of Health-Promotion and Quality of Life in Chronic
Disabling Conditions developed by Stuifbergen & Rogers (1997) has been validated
twice, first in persons with multiple sclerosis and second in persons with post-polio
syndrome (Stuifbergen, Seraphine & Roberts, 2000; Stuifbergen, Seraphine, Harrison, &
Adachi, 2004). This model describes how disease severity has an effect on healthpromoting behaviors and quality of life. Therefore, Stuifbergen’s Model of HealthPromotion and Quality of Life in Chronic Disabling Conditions is a good fit for this study
on health-promoting behaviors, hope, and HRQOL in persons with Parkinson’s disease.
According to Stuifbergen and Roger’s (1997) health promotion model, strategies
need to be priority for serving persons with chronic disabling conditions. The authors
describe health promotion fitting together with rehabilitation with a common goal of
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improving quality of life. In order for persons with chronic disabling conditions to
function at their full potential, they must engage in health-promoting behaviors.
Stuifbergen, Harrison, Becker and Carter (2004) verified health-promoting
behaviors decrease the influence of disease severity on QOL. Their research recommends
supporting health-promoting behaviors and self-efficacy to maintain and improve QOL.
Combining health-promotion and self-efficacy is a powerful strategy for working with
persons with chronic disease. The combination may lead to an improvement in health
when persons meet health goals despite disease progression. Empowering persons with
chronic diseases to use health-promoting behaviors is congruent with Pender’s (2015)
belief that health happens alongside the illness experience. Despite the limitations caused
by Parkinson’s disease in motor function or non-motor functions, the person still strives
for good health.
The explanatory model describes how the concepts of perceived barriers,
resources, and self-efficacy effect health-promoting behaviors (Meraviglia, Stuifbergen,
Parsons, & Morgan, 2013). The model discusses how severity of illness could impair
quality of life, but is remedied some by the mediating variables of health-promoting
behaviors and the antecedent variables of barriers, self-efficacy, resources, and
acceptance (Stuifbergen et al., 2004, p. 384).
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Figure 2. Explanatory model of health promotion and quality of life in chronic disabling conditions
(Stuifbergen & Rogers, 1997) used with permission from author.

Stuifbergen et al. (2004) describe the Explanatory Model of Health Promotion and
Quality of Life for Persons with Chronic Illnesses as follows: severity of illness impairs
quality of life, but is reduced by health-promoting behaviors and the antecedent variables
of barriers, self-efficacy, resources, and acceptance (p. 384). Severity of illness for
Parkinson’s disease patients increases as the disease reaches advanced stages. Healthpromoting behaviors include physical activity, nutrition, and stress management
(Stuifbergen et al., 2005). Barriers include problems with motor function, cognitive
function, and pain leading to decreased HRQOL. Self-efficacy improves health-promoting
behaviors and is a strength to persevere and meet goals (Marriner-Tomey & Alligood,
2010). Resources could link to finances, social support, and hope. Acceptance improves
coping skills and thus improved quality of life. The concepts of the model are described
in further detail below.
Severity of Illness. When severity of illness increases, barriers are expected to
increase (Stuifbergen & Rogers, 1997). Severity of illness for Parkinson’s disease
patients would affect their activities of daily living, being ability to dress or bathe
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themselves. Winter et al. (2010a, 2010b, 2011) discussed an average over 80% of patients
with Parkinson’s disease patients are dependent on cares mostly provided by family
members. This high number of persons depend on others to help them with their ADLs
because of their disease severity. Lou (2015) describes as severity of illness increases;
fatigue severity also increases leading to decreased HRQOL. Fatigue is associated with
several of the non-motor symptoms of Parkinson’s including apathy, sleep disorders,
cognitive dysfunction and depression.
Barriers. Problems with mobility, anxiety, depression, and pain are common
problems decreasing HRQOL in persons with Parkinson’s disease (Winter, 2011). These
problems could classify as possible barriers using this model. Few studies have
recognized the effect of depression in Parkinson’s disease. The impact depression has on
HRQOL is important to identify as depression is clearly associated with lower HRQOL
and health-promoting behaviors (Dowding, Shenton & Salek, 2006; Jones, Pohar, &
Patten, 2009; Schrag, 2006). Withdrawing from social life is another possible barrier that
could result in lower HRQOL for persons with Parkinson’s disease.
Self-efficacy. Research has indicated self-efficacy improves health-promoting
behaviors for not only persons with chronic disabling conditions, but for all persons
(Strecher et al., 1986; Stuifbergen & Becker, 1994). Self-efficacy allows persons with
Parkinson’s disease to be resilient and is essential to cope with chronic illness (Nelson,
Wong & Lai, 2011). Patients with a variety of chronic conditions were better able to
manage their symptoms and utilize health care services when they had perceived high
levels of self-efficacy (Lorig et al., 1999).
Resources. Key resources noted in Stuifbergen’s explanatory model are social
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support and income. In Stuifbergen’s study of persons with MS, emotional support was
linked to health-promoting behaviors (Stuifbergen, 1995). For persons with Parkinson’s
disease key resources could also link to social support. Social support was studied related
to coping and quality of life in Parkinson’s disease and found symptoms of Parkinson’s
disease are correlated with social implications (Schreurs, De Ridder, & Bensing, 2000)
For example, some of the symptoms of Parkinson’s disease such as tremors, motor
problems and apathy can lead to social isolation. Income is also a relevant resource for
persons with Parkinson’s disease because of high medical treatment costs. Typically,
private insurance will not pay for approval of medical treatment such as deep brain
stimulation (DBS). This expensive treatment works by implanting an electrode in the
brain to inhibit abnormal nerve signals and is sometimes referred to as a brain pacemaker.
This technique decreases tremors and improves abilities for persons to complete ADLs.
Patients who have had DBS report significant improvement in symptoms and higher
quality of life (Perestelo-Pérez et al., 2014).
Acceptance. The final approach used by persons with a range of chronic
disabling conditions to foster health-promoting behaviors is acceptance (McWilliam,
Stewart, Brown, Desai, & Coderre, 1996). The acceptance phase discusses how the
disease fits into the person’s lifestyle and does not equal giving up (Stuifbergen,
Seraphine, Harrison & Adachi, 2005). In persons with Parkinson’s disease acceptance
helps the patient cope, which in turn coping leads to significantly improved HRQOL
related to cognitive impairment, communication, and discomfort. Clinical interventions
program such as acceptance and group mindfulness programs may benefit HRQOL in
persons with Parkinson’s disease (Bucks et al., 2011).
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Conclusion
The literature supports the occupational risks of farming and pesticides associated
with Parkinson’s disease (Kenborg et al., 2012; Kamel et al., 2007; Wright Willis et al.,
2010). The increasing incidence of Parkinson’s disease as the population ages is
concerning for those at greater risk in farming communities in America. Parkinson’s
disease is associated with decreased HRQOL and studies show an increase in the Hoehn
and Yahr stage of disease severity correlates with even worse quality of life (Goetz et al.,
2004). On the contrary, the concept of hope is associated with an improvement in quality
of life. Hope has been studied in a variety of populations including healthy populations,
those with chronic diseases, and cancer (Dufault & Martocchio, 1985; Farran, et al.,
1990; Forbes, 1994; Duggleby et al., 2010; Herth, 1989; Rustoen, 1995). Hope improves
when a person received a hope intervention in persons with cancer, but no research has
established this connection in people with Parkinson’s disease.
HRQOL has been assessed in multiple populations including persons with
Parkinson’s disease (Sigstad et al., 2005; Leonardi et al., 2012; Miyashita et al., 2011;
Post et al., 2011; Rodriguez- Violante et al., 2013; Visser et al., 2009;Weintraub,
Moberg, Duda, Katz, & Stern, 2004; Welsch et al., 2003; Winter et al., 2010a, 2010b,
2011). An association of health-promoting behaviors and a strong HRQOL have been
established in the literature (Stuifbergen, 1995; Stuifbergen & Rogers, 2005; Stuifbergen,
et al., 2005). However, this specific association of health-promoting behaviors, HRQOL,
and hope has not been established for people with Parkinson’s disease which could have
a significant impact given the high incidence of Parkinson’s disease in the Midwest.
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The theoretical model by Stuifbergen et al. (2004) is a good fit for this study
because it describes quality of life for persons with chronic illnesses. The model has been
validated twice, once in persons with polio and once in persons with multiple sclerosis.
The health promoting behaviors measured in the model by Stuifbergen include physical
activity, nutrition, and stress management. Other health-promoting behaviors not
included in the model, but which will be measured in this study include health
responsibility, spiritual growth, and interpersonal relationships. See Health Promoting
Lifestyle Profile II Instrument (see Appendix C).
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CHAPTER 3: RESEARCH METHODOLOGY
Introduction
This chapter examines the research design used to organize the study. Plans for
sampling, instruments, data collection, and the data analysis in a systematic fashion are
described. The protection of human subjects and ethical considerations are reviewed.
Research Design
A descriptive correlational design was used to examine the relationships among
health-promoting behaviors, hope, and HRQOL in persons with Parkinson’s disease.
Descriptive research paints a picture of characteristics and situations as they happen
naturally in a single sample (Burns & Grove, 2011). A descriptive correlational design is
appropriate as this study examines the relationship among the variables of healthpromoting behaviors, hope, and quality of life portrays an image of life as it happens for
persons with Parkinson’s disease. According to Portney and Watkins (2009), a
correlational design describes relationships among variables and is exploratory in nature.
No attempt is made to control or manipulate the variables. Burns and Grove (2011) assert
that correlational descriptive studies review circumstances in the past or in the present
and can quickly identify many interrelationships in that situation. This type of design is
also helpful to develop hypotheses for future studies. The role of a covariate in statistical
data is to show the correlation among variables, directly or indirectly, without trying to
establish a causal relationship
Sample
According to Portney and Watkins (2009), the appropriate study sample size is
important determining the power of the test. If the sample is small, then the data is not
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likely an accurate portrayal of the population and increases the chance of an error. This
type of error happens when the researcher accepts the data as true when it is false. This is
a type II error, meaning that the researcher failed to discover the presence of the effect,
which is a false negative. Having a smaller sample size is also harmful because it
decreases the power of the test. Conversely, statistical power increases with a larger
sample. Power links directly to the sample size and is a critical ability of a test to find if
an effect truly exists (Field, 2014). A sample size of 176 was projected, using a power
analysis based on an alpha of 0.05, power of 0.80 and Cohen’s convention for a medium
effect (r = 0.30) (Polit & Beck, 2012) and a sample size of 179 was attained.
Participants were persons with Parkinson’s disease attending support groups in
the Midwest and attendees of the South Dakota 2016 Annual Parkinson’s Awareness
Conference. Participants were also from the Midwest Parkinson’s Foundation mailing
list. A convenience sample of persons with Parkinson’s disease who met inclusion
criteria for participation were included. This yielded a sample size of 179, which was
over the minimum sample size of 176 participants. The exclusion criteria included
persons with severe dementia or dysphasia, which impaired their ability to communicate.
The inclusion criteria for the study included English-speaking adults with
Parkinson’s disease. The population gave consent to participate by returning their survey.
The study population included both males and females. Participants in nursing homes and
assisted livings were also included in this study. Marital status was not an inclusion or
exclusion criteria.
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Setting
The study utilized Parkinson’s disease support groups located in a Midwestern
state. Initially data were collected from three cities in a Midwestern state. One of the
major cities, which is on the southeast side of the state, has a population of 168,586 (citydata.com, 2014). This community is the fastest growing metro area in this state
(Businessweek, 2011). Over 80% of the population is Caucasian and 90.7% of the
population has high school education (U.S. Census Bureau, 2014). The median age is
34.2 years (city-data.com, 2014). Another major support group is located in a city with a
population of 23,225 and is on the eastern side of the state (city-data.com, 2014). The
median resident’s age is 22.7 years, which is perhaps lower because of a university
located in the city. The third major city in this study has a population 22,057, which is
also on the eastern side of the state. The median age is 36.4 years (city-data.com, 2014).
All three cities have similar ethnicity and education percentages (U.S. Census Bureau,
2014).
Three additional support groups in different cities were added to the study to
reach the sample size. A support group was added in a city on the western side of the
state. This city has a population of 73,569 and 80% of the city is Caucasian. The high
school graduation rate in this city is 91.7%. The second additional support group was in
the southeastern part of the state. The city has a population of 22,702, and 92.5% of the
population is Caucasian. Like the other cities, the high school graduation rate is greater
than 90% (U.S. Census Bureau, 2015). The final city was in the eastern part of the state
and had a population similar in size to two of the other cities with a population of 22,574;
however, the high school graduation rate of this city was lower at 74.1% (U.S. Census
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Bureau, 2015). Several surrounding communities came to this support group and this
group had the highest attendance with 28 persons with Parkinson’s disease.
Support groups in these cities met monthly and offer support for persons with
Parkinson’s disease, their caregivers, and friends. Support groups also provided
education, socialization, opportunities to share worries or discuss new information on
Parkinson’s disease treatment. Support groups are free and open to anyone in the
community (Parkinson’s Association of South Dakota, 2016).
Instruments
Participants completed four instruments. First, a demographic instrument
collecting data on background information was used to describe the sample. Next, the
Health Promoting Lifestyle Profile II (HPLP II), the Herth Hope Index (HHI) and the
Parkinson’s disease questionnaire-8 item version (PDQ-8), which measures HRQOL in
Parkinson’s disease patients were administered. Additionally, disease severity was
assessed for each person based on the Hoehn and Yahr scale.
Demographic Instrument for Background Information. A demographic
instrument for collecting background was developed for the study (see Appendix A).
Basic demographic variables include age, gender, marital status, ethnicity, religious
affiliation, and length of time since diagnosis. Munro (2005) describes nominal data as
the lowest form of measurement because it limits the ability to control and perform
statistical tests on the data.
Hoehn and Yahr Scale. Disease severity was assessed based on the Hoehn and
Yahr scale (see Appendix B). Hoehn and Yahr (1967) developed a scale for practitioners
to stage Parkinson’s disease that is still commonly used today. The scale includes the
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following five stages:
1. Unilateral or one-sided involvement.
2. Bilateral, which involves both sides and mild disease.
3. Bilateral disease with worsening balance and mild to moderate disease.
4. Severe disease, which requires extensive assistance.
5. Confinement to bed or wheelchair unless assisted and possible tracheostomy or
feeding tube.
According to Bunting-Perry and Vernon (2007), the scale is not related to
prognostic factor as the progression of the disease is so variable for patients, but rather a
simple snapshot describing the persons’ current rating of disease. Medication timing and
dosing can change the outcome of the rating scale. Goetz et al., (2004) notes a lack of
formal psychometric properties such as reliability and validity of the Hoehn and Yahr
scale. The scale combines assessing disability and impairment. Because the scale is an
ordinal scale, reliability testing is limited. The scale stage was self-reported by persons
with Parkinson’s disease. Overall, the scale has widespread use and is accepted by those
in practice. In research, the scale is useful primarily in determining inclusion/exclusion
criteria.
Health Promoting Lifestyle Profile II Instrument Review. The instrument
chosen to measure health-promotion in this study was the Health Promoting Lifestyle
Profile (HLPL) II instrument (Walker, Sechrist, & Pender, 1995) (see Appendix C). The
psychometric properties of the scale include a strong internal consistency, Cronbach’s
alpha of .94 and with a test-retest reliability of .89 (Pender, 2011). The scale has 52 items
with a 4-point scale assessing how often participants engage in health-promoting
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behaviors. Six dimensions on the scale include health responsibility, nutrition, physical
activity, spiritual growth, interpersonal relationships, and stress management. A factor
analysis confirmed a six-dimensional structure of health-promoting behaviors. Content
validity was obtained by literature review and the content experts’ evaluation (Walker &
Hill-Polerecky, 1996). Each of the dimensions is scored separately as a specific subscale
and then together for a total score. Scores range from 1 (never) to 4 (routinely) and higher
scores equal greater health-promoting behaviors. The scale takes an estimated 10 minutes
to complete. Permission to use this tool was obtained from the author (N. Pender,
personal communication, March 28, 2016).
Hope Scale Instrument Review. This study used the Herth Hope Index (HHI) to
measure hope (see Appendix D). The HHI is a 12-item instrument for assessing hope in
adults and was developed from the 30-item Herth Hope Scale (HHS). It is used to assess
change related to how much an individual agrees with the statement at the moment of
completing the instrument. The items are rated on a Likert scale from 1 (strongly
disagree) to 4 (strongly agree) (Herth, 1992). The original hope scale items were created
to reflect Dufault and Martocchio’s (1985) concept of hope, which is the conceptual
definition used in this study.
The HHI was validated through factor analysis and internal consistency in a
convenience sample of 172 ill adults and has a Cronbach’s alpha= 0.78-0.97 (Herth,
1992; 1993). Test-retest reliability of 0.91 also indicates high stability of this scale
(Bluvol & Ford-Gilboe, 2004). The possible range of scores, once added together, range
from 12 to 48 (Herth, 1992). The initial Cronbach’s alpha was 0.94. The HHI pilot did
not show a ceiling or floor effect in the item mean effect of the instrument (Herth, 1992).
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Permission to use this tool was obtained from the author (K. Herth, personal
communication March 16, 2013).
Health-Related Quality of Life Instrument Review. This study used the PDQ-8
to measure HRQOL (see Appendix E). The PDQ-8 is widely validated and represents a
good instrument to measure HRQOL. The scale is also responsive to treatment effects
and is easily administered (Fereshtehnejad et al., 2014). The construct validity was based
on an exploratory factor analysis on evidence from eight measures representing the
subscales that have established reliability, internal consistency Cronbach’s alpha greater
than 0.7, and test-retest reliability was established. In the PDQ-8, the lower scores predict
higher HRQOL.
Multiple scales have been created to assess HRQOL in Parkinson’s disease. The
gold standard scale used most frequently to measure HRQOL in Parkinson’s disease is
the PDQ-39, which is the parent tool for the PDQ-8. The PDQ-8 has similar properties to
the parent tool and was chosen instead of the PDQ-39 because of ease of administration
and to prevent participant burden due to the large number of tools being used in this
study.
The domains of the PDQ-8 represent a dimension from each of the following
areas on the PDQ-39: “mobility, activities of daily living, emotional well-being, stigma,
social support, cognition, communication and bodily discomfort,” (Rodriguez-Violante et
al., 2013, p.11). The tool is free for use for scientific purposes and requires less than 10
minutes to administer. The shorter tool has a single index figure and a smaller number of
items. It has less participant burden and requires less time to administer than the 20
minutes of the PDQ-39.
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The PDQ-8 has been validated in several countries including the USA, Canada,
UK, Singapore, Greece, Italy, Spain, Persia, China, and Japan (Jenkinson & Fitzpatrick,
2007; Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman. 1997; Tan, Luo, Nazri, Li, &
Thumboo, 2004). Permission was obtained from the author to use the instrument (C.
Jenkinson, personal communication, March 8, 2013).
Data Collection
Human Subject’s Protection. Permission was obtained from the SDSU Human
Subject committee. Participants were told the purpose of the study, the risks and benefits
of the study, and nature of their contribution to the study. The participants were
guaranteed confidentiality. A letter of consent was given to each participant and return of
the surveys is considered their consent for participation. Confidentiality was upheld and
all names of participants, addresses or any identifiers were removed.
Subject Recruitment. The participants were recruited from support groups in a
Midwestern state. Average attendance at support group meeting is 20-40 persons. Each
group meets at a set time on a monthly basis in either the afternoon or evening.
Participants were also recruited at the South Dakota Annual Parkinson’s Awareness
Conference by a sign-up sheet for surveys to be mailed. The conference has an average
attendance of 100 persons. The number of participants from the projected three support
groups and conference did not meet the goal of the study; therefore, six additional
support groups were visited to obtain an adequate sample size.
Data Collection Process. At nine different support groups, persons were invited
to join the study. Prior to the meetings, support group leaders were contacted by email or
phone for permission to administer the survey at the meetings. A presentation was given
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at the support group meetings on nutrition at several of the meetings. The survey
instruments were given to those at the support group meetings and a large manila
envelope was placed in the back of the room for participants to return their survey once
completed.
The other surveys were mailed to those not in attendance at the support groups
with a return self-addressed stamp envelope (Appendix G). Dillman et al. (2014) was
used as a guideline for the data collection process for these surveys. Dillman describes
the importance of personalization and following up with participants using a five-contact
method during implementation to ensure high response rates. The first step was to
distribute letters explaining the study. These participants were mailed a reminder to
complete the survey and then finally a thank you letter was mailed once the survey was
completed and returned (see Appendix H).
Persons were also informed about the study at the South Dakota Annual
Parkinson’s Awareness Conference, where persons with Parkinson’s disease were asked
to sign up if they were interested in participating in the study. These participants were
mailed a survey and received reminders to complete and return the survey. A thank you
letter was mailed to them once the survey is complete.
Analysis
Statistical analyses were conducted using IBM Statistical Package for the Social
Sciences (SPSS 21.0). Statistical tests were used to measure the relationships between
hope, health promoting factors, and health-related quality of life. The data from the
survey responses were typed by hand and entries were double-checked by researcher after
numbers were imported into SPSS.
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Pearson’s correlation coefficient was used to measure the strength of the
relationship between the variables to quantify the relationship between hope, healthpromoting factors and HRQOL. A significance level or alpha level of p < 0.05 was used
and a one tailed t- test was used to test if Pearson’s correlations were significant. The
following hypotheses were tested: 1) There is a positive relationship between hope and
health-promoting behaviors, and 2) There is a positive relationship between health
promoting-behaviors and hope on HRQOL. 3) Hope and health-promoting behaviors may
predict HRQOL modifying for disease severity. The variables of hope, health-promoting
behaviors, and HRQOL were measured in multiple regressions and a path analysis.
According to Munro (2005), multiple regressions are used to predict outcomes. In this
study, multiple regressions were used to identify statistical significant predictors of
health-promoting factors and HRQOL. Multiple regressions tested the variances
recognized as enablers and obstacles for hope and health-promoting behaviors.
A path analysis tests for the relationship between independent and dependent
variables (Murnro, 2005). In this study, a path analysis determined the relationship
between the independent or antecedent variables of hope, health-promoting behaviors and
the dependent- outcome variables of HRQOL. Direct and indirect effects of confounding
variables were evaluated.
Demographic data was analyzed using frequency numbers and percentages from
participants. The background information sheet for demographics was collected.
Relationships were reported between the background demographic data to hope and
health-promoting behaviors using correlational matrixes. A t-test was used for exploring
differences between the means (Polit & Beck, 2012) of the demographic variables.
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variables will be studied by using non-parametric tests if the group size is not equal
(Field, 2014).
Missing Values
Missing values were assessed if they were occurring randomly or non-random.
Less than five percent of a total missing values is considered ignorable and no pattern
occurred (Hair et al., 2010). These authors also recommend deleting variables that are
missing15 percent of data. The Most Completely at Random (MCAR) test assessed if
data were missing independently and no cases were identified as problematic in this
sample. Assessing the missing data found no patterns were and 0.27% values were
missing for overall data.
For this research, an imputation technique was used to replace missing data with
the mean. According to Munro (2005), one process of imputation uses the mean
replacement because this procedure does not change the distribution and is a conservative
way to validate missing numbers to provide a complete data set.
Threats to Reliability and Validity
Burns and Grove (2011) describe three ways to provide protection against threats
to validity in a descriptive design study. First links need to be present for conceptual and
operational definitions of variables. In this study, the conceptual definition of hope by
Dufaut and Martocchio (1985) was operationalized in the questions of the HHI tool. The
other definitions and tools are connected. The second way to protect against bias relates
to sample selection and size.
The sample selection and size may be skewed compared to the general population
of patients with Parkinson’s disease because the sample is selected in the Parkinson’s
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disease belt where patients have higher prevalence and incidence of the disease. In
addition, the sample may have more ethnically similar individuals who are genetically
susceptible to Parkinson’s disease residing in this geographic area of the study. The final
way to protect from bias is to use valid and reliable instruments for data collection
procedures. This study’s instruments have solid validity and reliability.
Summary
This study examines the relationship of health-promoting behaviors, hope, and
HRQOL for persons with Parkinson’s disease. Additionally, hope and health promoting
behaviors may help ease the burden of the disease and possibly lead to a positive effect
on quality of life. The study methods, procedures, and instruments are reviewed.
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CHAPTER 4: RESULTS AND ANALYSIS
Introduction
This chapter presents the results of the research and describes the demographics
of the sample, variable testing, and results of test validity and reliability. The data were
collected in surveys and responses entered by hand into an Excel spreadsheet and doublechecked by researcher. Then the data were imported into the IBM Statistical Package for
the Social Sciences (SPSS) version 22 for statistical analysis. The purpose of this study
was to determine the relationship between hope, health-promoting behaviors, and
HRQOL in persons with Parkinson’s disease. A statistician was consulted for the review
of results and analysis.
This study was designed to answer specific research questions. The results from
the first research question analyzed the level of hope in persons with Parkinson’s disease.
The findings from the second question described the relationship between hope and
health-promoting behaviors on HRQOL in persons with Parkinson’s disease. The results
from the final question examined the relationship among hope, health-promoting
behaviors, and HRQOL, while controlling for disease severity.
Sample Characteristics
A convenience sample was selected of participants from Parkinson’s disease
support groups and the South Dakota Parkinson’s Awareness Conference. The survey
was completed by persons with Parkinson’s disease at nine support groups in a Midwest
state between July and December 2016. The groups ranged from seven to 34 attendees
per meeting. One person attending the support group had another neurologic disease
other than Parkinson’s disease, and that survey was excluded. Eight surveys were
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excluded due to incomplete survey tools. There were 149 surveys returned from support
groups and South Dakota Parkinson’s Awareness Conference, which accounted for 83%
of the total participants.
Additional participants from a mailing list from the Midwest Parkinson’s
Foundation received a pre-notice letter (n=100) introducing the study. Those participants
received the survey by mail and 30 returned the survey, a return rate of 30%. The 30
mailed surveys account for 17% of the total sample. Their primary care provider or a
neurologist had told all participants they had Parkinson’s disease.
Results and Analysis
Setting. The persons in the support groups and at the conference were handed the
pre-notice letter to participate in the study. Next, they were given the cover letter, which
stated informed consent if the survey was returned. Lastly, they were given the packet of
surveys with the Herth Hope Index, HPLP-II, PDQ-8 questionnaires, and a self-addressed
stamped return envelope.
Participants from the mailing list were mailed the pre-notice letter to participate in
the study. Then they were mailed the cover letter, which stated informed consent if the
survey was returned. Finally, the packet of surveys with the Herth Hope Index, HPLP-II,
PDQ-8 questionnaires, and a self-addressed stamped return envelope was mailed.
Participants were requested to return the questionnaires in the self-addressed stamped
return envelope. These participants were also mailed a letter two weeks after the survey
was mailed, thanking them if they had already completed the survey and reminding them
to complete the survey if they had not already done so. Total surveys were distributed to
250 persons.
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Demographic Data. The demographic variables collected were age, gender,
marital status, ethnicity, time (in years) since the diagnosis, and whether the participant
grew up on a farm. The antecedent variables or independent variables were hope, healthpromoting behaviors, and disease severity. The outcome variable or dependent variable
was HRQOL. Descriptive statistics were performed on demographic characteristics.
Demographic Results. Persons with Parkinson’s disease (N =179) completed the
survey. Persons with Parkinson’s disease who completed the survey were almost
exclusively Caucasian. Participants were predominantly male, 60.9%. The age ranged
from 37 to 96, and the majority of participants were between 66 and 75. Most participants
surveyed had been diagnosed between one to five years prior. Fewer than half of the
participants, 45.3%, had grown up on a farm or in a rural area.
Age. Fifty-three percent were diagnosed with Parkinson’s disease between one to
five years prior. The mean age of the study sample participant was 73 years. The median
age of the study participants was 74 (see Table 1). The mean age for persons in the
United States with Parkinson’s disease is unknown. According to the Parkinson’s Disease
Foundation, the national average of diagnosis is 60 years. The participants in this study
were generally diagnosed with Parkinson’s disease later in life than the national average
age of diagnosis of 60 years (PDF, 2016).
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Table 1
Age of Study Participants_______
Age
Participants
<55
7
56–60
6
61–65
19
66–70
37
71–75
41
76–80
28
81–85
28
>85
13

______
Percent
3.9
3.3
10.6
20.7
22.9
15.6
15.6
7.4____

Gender. According to national data from the Parkinson’s Disease Foundation
(2016), males are 1.5 times more likely to have Parkinson’s disease than females.
Participants in this study were 60.9% male and 39.1% female. This study aligned with the
Parkinson’s Disease Foundation data, with 1.6 times more males than females (see Table
2).

Table 2
Gender of Study Participants__________________
Gender
Participants
Percent
Male
109
60.9
Female
70
39.1___

Ethnicity. Study participants were 98.3% Caucasian, 1.1% Hispanic, and 0.6%
Japanese (see Table 3). To date, very few studies have collected data on ethnicity.
Research is not conclusive if disease varies by ethnicity. Most studies reviewed included
Caucasian. Some studies noted by Kaiser Permanente Research (1994–1995) showed that
African Americas and Asians were at less risk to develop Parkinson’s disease; however,
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Parkinson’s disease affects people from all ethnicities and backgrounds, regardless of
social economic status or geography (Van Den Eden et al., 2003).
Table 3
Ethnicity of Study Participants_________________
Ethnicity
Participants
Percent
White/Caucasian
176
98.3
Hispanic
2
1.1
Japanese
1
0.6____
Relationship Status. The majority of participants, 78.2%, were married, and
11.7% were widowed. The remaining 11.1% were divorced, single, separated, or in
relationships but not married (see Table 4).
Table 4
Marital Status of Study Participants_______________
Marital Status
Participants Percent
Divorced
9
5.0
In relationship, not married
2
1.1
Married
140
78.2
Separated
1
0.6
Single, never married
6
3.4
Widowed
21
11.7___

Length of Time Since Diagnosis. The mean number of years since diagnosis was
7.11 years. The median number of years was five years. The majority (82%) of the
persons in the support groups were diagnosed within the last 10 years, 53% were
diagnosed between one and five years and 29% between six and 10 years (see Table 5).
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Table 5
Number of Years since Diagnosis________________
Diagnosis in years
Participants_________Percent_
1-5
95
53%
6-10
51
29%
11-15
15
8%
16-20
9
5%
>20
9
5%____
Time on Farm. Over half of the participants did not have a farming background.
Eighty-one participants, or 45.3% of the sample, grew up on a farm (see Table 6).
Previous research found pesticides from agriculture increases the risk for Parkinson’s
disease (Gatto et al., 2009; Marder et al., 1998; Morano et al., 1994; Smargiassi et al.,
1998; Wang et al., 1993; Wechsler et al., 1991; Wong et al., 1991). Possibly, the number
of persons in attendance at the support group was lower for those associated with
agriculture because it was during harvest.
Table 6
Participants Who Grew Up on a Farm____________
Farming background Participants
Percent_
Yes
81
45.3
No
97
54.2___
Analysis of Demographics. Demographic comparison to statistics for persons
with Parkinson’s disease was challenging because the United States is lacking a current
accurate reporting system. The scarcity of data on the incidence of Parkinson’s disease is
likely to improve because on December 13, 2016, President Obama signed the Cures Act
into law. This will allow the Centers for Disease Control and Prevention (CDC) to collect
demographics on sex, age, ethnicity, and geographic distributions of Parkinson’s disease
and other neurologic diseases in the US. The new reporting system, National
Neurological Conditions Surveillance System at the CDC, will help increase
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understanding of demographics and strengthen future research when implemented (Falce,
2016).
Summary of Demographic Data Analysis. Demographic standards for
comparison were difficult to attain due to lack of national reporting system. The data
collected by the PDF shows that for the support groups in this study the baseline for
diagnosis is at a higher age than the national average of diagnosis of 60. This may be
related to lack of providers that are specialists in the state for neuromuscular disorders, or
there may be a delay in seeking treatment with early signs of Parkinson’s disease.
Education on signs and symptoms for persons to report to a doctor and better screening
by providers is needed to improve diagnosis. Delayed onset of disease could also be a
possibility. The study’s data on gender for men being more likely than women was
almost identical. The ethnicity was predominantly Caucasian at 98%. This aligns with
data from the Parkinson’s disease foundation and from a study by Kaiser Permanente that
found that the majority of the incidence for Parkinson’s disease is Caucasian (13.5 per
100,000) (PDF. 2016; Van Den Eeden et al., 2003).
The length of time since diagnosis correlated with a high number of persons who
were recently diagnosed, suggesting it is more common to seek out social support during
the first 10 years from the time of diagnosis. Those attending the support groups did not
have a strong correlation with growing up on the farm, even though studies have noted
the risk of farming is associated with Parkinson’s disease and associated chemicals
(Kenborg et al., 2012; Wright Willis et al., 2010). In this study, less than half of
participants grew up on a farm. This may be explained because those farming possibly
are less likely to attend support groups. Additionally, persons with Parkinson’s disease
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who are still farming may have been too busy to attend the support groups in the fall, as
data were collected during harvest time.
Analysis of Multivariate Methods
Three multivariate methods were used in the analysis. The first method completed
was the exploratory factor analysis (EFA), which extracts factors or dimensions from a
large set of variables. Next, a confirmatory factor analysis (CFA) was used to determine
and measure the goodness of fit of the factor structure for the sample data (Hair, Black,
Babin, & Anderson, 2010). Finally, a path analysis was completed using AMOS 19.0 to
measure the relationship between dependence, independent, and moderator variables
(Munro, 2005). Tests were completed to analyze the assumptions of the path analysis.
Factor Analysis
Exploratory factor analysis (EFA) clarifies how the observed items and latent
variables are related to one another (Byrne, 2010). Using the EFA process, underlying
factors or dimension among the selected input variables were extracted in the analysis.
These dimensions were assumed to represent factors that are highly inter-correlated
among the large variable set of survey items.
Prior to running the factor analysis, the EFA assumptions were considered
appropriate for use of the model. EFA assumptions or requirements includes sample size
considerations, intercorrelation of the input variables, measure of sampling adequacy,
total variance explained, average factor loading, measure of reliability, convergent and
discriminate validity (Hair et al., 2010; Williams, 2012). According to Tinsley & Brown
(2000), if these assumptions are not met, the power will be reduced and the chance of a
Type 1 error is greatly increased. The recommended sample size should be 100 or larger
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for factor analysis (Hair et al, 2010; Field, 2014). This study’s sample size, n =179, is
appropriate for an EFA design.
Factor rotation used in the study was an oblique rotation using Promax rotation.
According to Portney & Watkins (2009) oblique rotation is easy to interpret and
conceptually simple. Eigenvalues represented the amount of variance that belonged to a
factor and was a statistic used as a cutoff point to limit the number of factors in the
analysis. Only factors having eigenvalues greater than one are considered significant and
values less than one are disregarded (Portney & Watkin, 2009). Finally, the scree-plot
and factor loadings (correlations between the original variables and the factors) were
examined using criteria of ±.30 threshold established by Hair et al (2010). Correlation
coefficients over ±.30 are good indicators of factorability (Tabachnick & Fidell, 2007).
Hair et al. (2010) describes EFA as a process that identifies representative
variables from a much larger set of variables for use in subsequent multivariate analyses.
EFA was completed in this analysis to help explain how the observed number of survey
items related, 52 items on the HPLP-II scale, 8 items on the HRQOL scale, and 12 items
on the hope scale, which equaled 72 total input variables. This large number of variables
excluded the demographic profile questions.
Extracted Factors
The results of factor analysis extraction method identified seven dimensions:
spiritual growth, HRQOL, health responsibility, physical activity, nutrition, and the
combination of hope and HRQOL. A total of seven dimensions with eigenvalues greater
than 1.0 were identified (see Table 7). This explains 55% of the cumulative variance of
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the extracted factors from the data, which is well above the threshold for cutoff suggested
by Hair et al. (2010). Examining the scree plot (see Figure 3) identified seven extracted
factors, the line of the infliction point separates seven significant eigenvalues greater than
1.0 from eigenvalues (below 1.0) that are not significant. Out of the 72 input variables
selected for factor extraction, 42 input variables showed adequate factor loads to their
respective factors. Average commonality (common variance) across the factors was .549,
(see Table 8) which was higher than the .30 threshold established by Hair et al., (2010).

Figure 3. Scree plot.
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Table 7
Total Variance Explained
Initial Eigenvalues
Extracted Factors
Total
Spiritual Growth (SG)
Quality of Life (QOL)
HOPE
Health Responsibility (HR)
Physical Activity (PA)
Nutrition
HOPE/QOL

9.798
3.300
3.114
1.972
1.924
1.600
1.554

% of
Variance
23.328
7.858
7.415
4.696
4.580
3.810
3.699

Cumulative
%
23.328
31.185
38.601
43.297
47.877
51.687
55.386

Rotation Sums
of Squared
Loadings
Total
8.050
4.172
5.949
3.897
3.509
3.024
2.808
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Table 8
Communalities of Factor Loadings___________________________________________
Factor
Communality
Factor
Communality
RevQOL2
0.599
HPLP18
0.757
RevQOL5
0.609
HPLP24
0.741
RevQOL5
0.624
HPLP12
0.649
RevQOL8
0.495
HPLP17
0.578
RevQOL3
0.594
HPLP23
0.543
Average
HPLP36
0.621
Communalities
0.549
HPLP30
0.575
HPLP6
0.504
HPLP19
0.588
HPLP35
0.559
HPLP39
0.579
HPLP27
0.489
HPLP15
0.480
HPLP31
0.543
HPLP51
0.478
HPLP43
0.430
HPLP10
0.645
HPLP4
0.638
HPLP28
0.553
HPLP16
0.428
HPLP46
0.416
HPLP2
0.519
HPLP8
0.483
HPLP26
0.468
HPLP44
0.463
HPLP9
0.402
HPLP20
0.540
HOPE3
0.487
HOPE6
0.352
HOPE7
0.518
HOPE8
0.600
HOPE9
0.569
HOPE11
0.735
HOPE12
0.754
RevQOL7
0.362
RevQOL4
0.493
RevQOL1
0.606
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Factor Loadings
According to Hair et al. (2010), factor loadings are the correlation of the input
variables within each extracted factor. Hair et al. established factor loading criteria with
ranges from ±.30 to ±.40 to meet the minimal level for interpretation of structures
(factors) and loadings ±.50 or greater are considered practically significant. Six of the
seven extracted factors have average factor loadings greater than 0.50, which verifies the
significance of the factor loadings within each of the structures (factors/dimensions) from
the data set and one extracted factor in the combination of Hope/HRQOL had average
loading less than the standard threshold. The hope/HRQOL combination dimension had
an average factor loading= 0.419 (see Table 9).
Factor loading of each input variable to their respective factor or dimensions were
measured. The spiritual growth dimension had an average factor loading = 0.81. HRQOL
dimension had an average factor loading = 0.626. The hope factor had an average factor
loading = 0.672. Health responsibility dimension had an average factor loading = 0.559.
Nutrition dimension had an average factor loading = 0.538.
In terms of the average loadings at the scale level, HPLP had an average factor
loading = 0.598. Hope had an average factor loading = 0.672. HRQOL had an average
factor loading = 0.522. All reached the threshold of 0.50 and so are considered
significant.
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Table 9
Pattern Matrix: Dimension level

Cronbach's Alpha
HPLP24
HPLP18
HPLP23
HPLP35
HPLP30
HPLP12
HPLP36
HPLP17
HPLP6
HPLP19
Average Factor
Loadings:
RevQOL5
RevQOL1
RevQOL2
RevQOL6
RevQOL8
Average Factor
Loadings:
HOPE11
HOPE12
HOPE7
HOPE9
HOPE8
Average Factor
Loadings:
HPLP39
HPLP27
HPLP15
HPLP51
HPLP31
HPLP43
Average Factor
Loadings:
HPLP4
HPLP10
HPLP28
HPLP16
HPLP46
Average Factor
Loadings:
HPLP8
HPLP2
HPLP26
HPLP44
HPLP9
HPLP20
Average Factor
Loadings:
HOPE3
RevQOL7
RevQOL3
RevQOL4
HOPE6
Average Factor
Loadings:
Extraction Method: Maximum
Likelihood.
Rotation Method: Promax with
Kaiser Normalization. a
a. Rotation converged in 7 iterations.

Spiritual
Growth
(0.890)
0.819
0.749
0.731
0.674
0.663
0.625
0.552
0.541
0.520
0.406

Quality of
Life
(0.784)

Hope
(0.846)

Factor
Health
Responsibility
(0.770)

Physical
Activity
(0.788)

Nutrition

Hope/QOL

(0.735)

(0.670)

0.628
0.696
0.681
0.667
0.655
0.429
0.626
0.831
0.701
0.678
0.586
0.564
0.672
0.772
0.625
0.578
0.492
0.475
0.413
0.559
0.851
0.847
0.697
0.491
0.390
0.655
0.724
0.721
0.473
0.464
0.453
0.394
0.538
0.526
0.407
0.406
0.396
0.358
0.419
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The Goodness of Fit test concerning the terms of model fit of the extracted factor
model (EFA) is found in Table 8. According to Hair et al. (2010), the measure of model
fit using Chi- Square/Df of less than 3.0 is a sign of adequate fit. The study’s ChiSquare/Df = 1.43 indicated a parsimonious fit of the model at the EFA stage (see Table
10).
Table 10
Goodness-of-Fit Test________________
Chi-Square

df

843.278

588

Chi-Square/Df
1.43*_____

*Model Fit Threshold= <3
Validation of the Extracted Factors
According to Portney and Watkins (2009), there are three steps to consider for the
validation process of extracted factors. The first is to consider the discriminate validity,
which analyzes whether the factors are distinct and uncorrelated. The second step
evaluates the convergent validity, which assesses the degree to which two or more
measures of the same concept are correlated. The final step checks the inter-item
reliability, or the extent to which a variable or set of variables is consistent in what it is
intended to measure.
Discriminant Validity. The Factor Correlation Matrix (see Table 11) displays the
correlation coefficients between the seven factors to test for discriminant validity. The
table presents the relative measure of the strength of the relationship between the five
extracted factors. Validation of the extracted factors should not be greater than the
correlation coefficient of ±0.70 (Gaskin, 2012) to have discriminate validity. This
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assumption of a correlation coefficient less than 0.70 relates to the issues with severe
high correlation between two factors, which indicates that those factors’ individual
contributions are reduced. Variables need to be distinct and uncorrelated to have validity.
No bivariate correlation coefficient greater than 0.70 was shown after the inspection of
the factor correlation matrix, which indicates that each of the extracted factors are distinct
and this study shows discriminant validity was achieved.
Table 11
Factor Correlation Matrix
Factor

SG

QOL

HOPE

HR

PA

Nutrition

HOPE/QOL

SG

1

0.422

0.599

0.345

0.272

0.242

0.333

QOL

0.422

1

0.197

0.085

0.268

0.144

0.128

HOPE

0.599

0.197

1

0.402

0.239

0.165

0.230

HR

0.345

0.085

0.402

1

0.189

0.232

0.062

PA

0.272

0.268

0.239

0.189

1

0.343

-0.076

Nutrition

0.242

0.144

0.165

0.232

0.343

1

-0.030

HOPE/QOL

0.333

0.128

0.230

0.062

-0.076

-0.030

1

Similarly, bivariate correlations (see Table 12) between the three scales have
shown no bivariate correlation greater than 0.70. Therefore, each of the three scales are
distinct. This confirms that discriminant validity was achieved at the higher order.
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Table 12
Correlation Matrix between the 3 Scales

HPLP

HOPE

QOL

Pearson
Correlation
Sig. (2-tailed)
N
Pearson
Correlation
Sig. (2-tailed)
N
Pearson
Correlation
Sig. (2-tailed)
N

HPLP

HOPE

QOL

1

.549**

.458**

179

0.000
179

0.000
179

.549**

1

.308**

0.000
179

179

0.000
179

.458**

.308**

1

0.00
179

0.00
179

179

Convergent Validity. According to Hair et al. (2010), the threshold for loadings
should be greater than 0.5 to have sufficient loading, regardless of sample size. Average
factor loadings for each of the two factors were greater than 0.50. Upon examination of
Tables 9 and 10, six of the seven extracted factors have adequate factor loadings greater
than expected threshold except the Hope/HRQOL combination. Overall, the indicator
variables converged well together with their respective factors and convergent validity
was achieved.
Inter-Item Reliability. In exploratory research, Cronbach’s Alpha value above
.70 is a good measure of inter-item level consistency (Hair et al., 2010). The inter-item
reliability tests whether the extent variables or sets of variables are consistent in what it is
intended to measure. This is different from validity of the extracted factors because it
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does not relate to what should be measured, but rather instead to how it is measured (Hair
et al., 2010).
Another measure of reliability is internal consistency. This applies to the
consistency among the variables in a summated scale. Internal consistency describes how
the individual items or indicators of the scale should all be measuring the same construct
and thus be highly inter-correlated (Byrne, 2010; Tinsley & Brown, 2000).
The spiritual growth factor’s internal consistency was, α = .890. The HRQOL
factor’s internal consistency was, α = .784. The hope factor’s internal consistency was, α
= .846. The health responsibility factor’s internal consistency was, α = .770. The physical
activity factor’s internal consistency was, α = .788. The nutrition factor’s internal
consistency was, α = .735. The hope/HRQOL combination factor’s internal consistency
was, α = .670. This indicates that the individual items within each dimensions achieved a
good level of internal consistency, and therefore achieved inter-item consistency.
Confirmatory Factor Analysis (CFA). According to Field (2014), the CFA is an
important step to test hypotheses and the relationships between the latent variables. This
is important because these latent variables are related to variables that can be measured,
but cannot be measured directly. Hair et al. (2010) describes three assumptions that need
to be met for the CFA process. First, significance of the indicator variables to their
respective factors or dimension must be established. Then model fit of the factor model.
Lastly, reliability of the factor model is tested.

72

Figure 4. Confirmatory factor model diagram.

Figure 4 is the diagram of the final confirmatory factor structure model. To
achieve adequate model fit, modification indices (covariance of the error terms) offer
remedies to discrepancies between the proposed and the estimated model and
modification index value. Greater than 15.0 is a good indicator to covary the error terms
of the same factor to improve model fit (Gaskin, 2012).
Several error terms existed in the model. Each covaried terms have similar item
structure and thus covarying their error terms was appropriate to improve goodness of
fit. Additionally, six HPLP items (HPLP 8, 28, 20, 46, 10, and 51) were dropped
because of their large residual errors between the proposed and estimated CFA model.
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Covariation existed between the items listed below:
1. HPLP item 15 “Question health professionals in order to understand their
instructions” and HPLP item 39 “Ask for information from health
professionals about how to take good care.”
2. HPLP item 27 “Discuss my health concerns with health professionals” and
HPLP item 39 “Ask for information from health professionals about how to
take good care” also showed covariance.
3. HPLP item 15 “Question health professionals in order to understand their
instructions” and HPLP item 27 “Discuss my health concerns with health
professionals.”
4.

HPLP item 31 “Touch and am touched by people I care about” and HPLP
item 43 “Get support from a network of caring people.”

5. HPLP item 4 “Follow a planned exercise program” and HPLP item 16 “Take
part in light to moderate physical activity.”
6. HPLP item 2 “Choose a diet low in fat, saturated fat, and cholesterol” and
HPLP item 44 “Read labels to identify nutrients, fats, and sodium content in
package food.”
7. HRQOL item 5 “Had problems with concentration” and HRQOL item 6 “Felt
unable to communicate with people properly.”
8. HRQOL item 1 “Had difficulty getting around in public” and QOL item 2
“Had difficulty dressing myself.”
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Table 13
Regression Weights: CFA
HPLP9
HPLP44
HPLP26
HPLP2
HPLP16
HPLP4
HPLP43
HPLP31
HPLP15
HPLP27
HPLP39
HPLP19
HPLP6
HPLP17
HPLP36
HPLP12
HPLP30
HPLP35
HPLP23
HPLP18

<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<---

HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP
HPLP

HPLP24

<---

HPLP

RevQOL5

<---

QOL

RevQOL1
RevQOL2
RevQOL6
RevQOL8
HOPE3
RevQOL7
RevQOL3
RevQOL4
HOPE6

<--<--<--<--<--<--<--<--<---

QOL
QOL
QOL
QOL
QOL
QOL
QOL
QOL
QOL

HOPE11

<---

HOPE

HOPE12
<--HOPE
HOPE7
<--HOPE
HOPE9
<--HOPE
HOPE8
<--HOPE
***p <.001, ** p<.01, *p<.05

Estimate
0.330
0.287
0.298
0.223
0.337
0.236
0.342
0.544
0.321
0.307
0.472
0.731
0.782
0.642
0.858
1.009
0.959
0.848
0.837
1.101
1 (Fixed
parameter)
1 (Fixed
parameter)
1.118
0.958
1.033
1.003
0.756
0.863
1.324
0.92
0.628
1 (Fixed
parameter)
1.156
0.589
0.711
0.844

S.E.
0.086
0.123
0.095
0.101
0.108
0.119
0.097
0.086
0.105
0.097
0.103
0.089
0.098
0.081
0.089
0.095
0.106
0.099
0.098
0.095

C.R.
3.829
2.33
3.154
2.214
3.123
1.979
3.529
6.32
3.057
3.168
4.597
8.188
7.981
7.955
9.683
10.568
9.089
8.556
8.567
11.617

P
***
*
**
*
**
*
***
***
**
**
***
***
***
***
***
***
***
***
***
***

~

~

~

~

~

~

0.23
0.215
0.144
0.203
0.155
0.204
0.223
0.173
0.147

4.861
4.448
7.152
4.931
4.894
4.237
5.935
5.332
4.27

***
***
***
***
***
***
***
***
***

~

~

~

0.083
0.073
0.083
0.085

13.899
8.043
8.541
9.889

***
***
***
***
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Regression weights (see Table 13) for each of the indicator variables were
manifested by their respective factors. Three fixed parameters (not estimated) were
needed to find model convergence or model solution of the maximum likelihood
algorithm. Each of the regression weights were statistically significant. This confirms that
the model structure proposed by the study is satisfactory. Table 14 describes measures of
model fit, using Hu and Bentler (1999) conventions of goodness-of-fit indices. This
three-factor model structure achieved adequate and reasonable model fit. The extracted
factors provided the study with a robust factor model, which was used in the study’s
hypothesis-testing stage. The construct reliability of the confirmed factor structure model
is shown to have an adequate inter-item consistency greater than the standard threshold
value of 0.70, QOL = .792, HPLP = .857, and hope = .844 (see Table 15).
Table 14
Model Fit Indices
Acceptable Thresholds

Observed
Model Fit
1.74

CMIN/DF

Between 2-5*

CFI

> .95 great; > .90 traditional; > .80
permissible *

0.82

RMR

< .07*

0.06

RMSEA

< .05 good; .05 - .10 moderate; > .10
bad*

0.07

*Hu and Bentler (1999)
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Table 15
Construct Reliability
QOL

0.792

HPLP

0.857

HOPE

0.844___

Threshold= >0.70
After meeting the assessment of the reliability test, convergent validity,
discriminant validity, and confirmation of model fit of the factor model, a summated
scale or a composite variable was created. This scale combined each of the survey items
or indicator variables to their respective factors to facilitate the statistical calculation of
the hypothesized path models. The three composite variables were used to test for the
five assumptions of the multivariate regression method to assess for appropriateness of
method used.
Path Analysis (Multivariate Regression) Assumptions
The first assumption tested if normal distribution existed among the input
variables. Next, the assumption was tested to see if the model was unidirectional, having
a linear relationship between the dependent and independent variables. Multicollinearity
was also tested in order to determine whether extreme correlations between independent
variables were present. Assumptions of homogeneity/homoscedasticity were then
evaluated to assess if the residual variances of Y (outcome) were equally the same for the
level of X (predictors). Finally, independent of errors or residual terms were tested (Hair
et al., 2010; Munro, 2005).
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Normality. The first assumption examined whether the input variables estimated normal
distribution visually. Pictures of histograms and boxplots determined influential outliers.
Shapiro-Wilk’s test of normality is a conservative test for normal distribution. The test
was conducted to approximate normality and observe skewness and kurtosis values
against an accepted threshold value (Field, 2014).
Figure 5 displays the histograms with the fitted normal curve. Examination of the
histogram graph for dependent variable, HRQOL, shows the spread of the distribution
has an asymmetric shape with a slight negative or left-skewed distribution, or left tail.
Similarly, the predictor variable hope displays an asymmetric distribution with a slight
negative or left skewed as evidence of the extended left tail. Lastly, the independent
variable HPLP appears to depict a symmetric distribution with equal lengths of the right
and left tails of the curve.

78

i. QOL

iii. HPLP
Figure 5. Histograms with fitted curves.

ii. HOPE
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Outlier Detection

i. QOL

ii. HOPE

iii. HPLP
Figure 6. Boxplots.

Examination of the boxplots (see Figure 6) notes the presence of influential
outliers detected in both the HRQOL and hope variables. Several cases below the
minimum level of the bottom 25% of the HRQOL and hope scores were evident. Outliers
were not significant for the HPLP variable.
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Table 16
Summary of Statistics
N
Mean
Std. Deviation
Skewness
Std. Error of
Skewness
Skewness Ratio
Kurtosis
Std. Error of
Kurtosis
Kurtosis Ratio

QOL
179
2.592
0.503
-0.521

HOPE
179
3.081
0.480
-0.379

HPLP
179
3.423
0.640
-0.275

0.182

0.182

0.182

-2.863
0.068

-2.082
0.256

-1.511
-0.593

0.361

0.361

0.361

0.188

0.709

-1.643

Examination of the summary statistics (see table 16) shows the input variables
and skewness/kurtosis estimations. The dependent variable, HRQOL, showed a negative
skewed distribution (skewness statistic = -0.521) and had a positive kurtosis value
(kurtosis statistic = 0.068). This indicated a very slight evidence of distribution with
peaked distribution characteristics. The independent variable, hope, had a negative
skewed distribution (skewness statistic = -0.379), and its kurtosis had a positive kurtosis
value (kurtosis statistic = 0.256), which also indicated evidence of distribution with
peaked distribution characteristics. The independent variable, HPLP, displayed a slight
negative skewed distribution (skewness statistic = -0.275) and had a negative kurtosis
value (kurtosis statistic = -0.593) indicated as evidence of platykurtic or with distribution
with flat distribution characteristics. Warner (2013) suggested that skewness and kurtosis
values of -1 to +1 are considered ideal, whereas values ranging from -2 to +2 are
considered acceptable. Following this convention guideline by Warner (2013) suggests
each of the input variables demonstrated normal distribution.
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Table 17
Test of Normality 1

HOPE
QOL
HPLP

Statistic
0.937
0.975
0.982

Shapiro-Wilk
df
179
179
179

Sig.
0.000
0.003
0.020

*. This is a lower bound of the true
significance.
a. Lilliefors Significance Correction

For the Shapiro-Wilk’s test of normality, an S-W value of 1.0 and a nonsignificant p-value designates the given data is perfectly normal (Tabachnick & Fidell,
2007). The Shapiro-Wilk’s test of normality (see Table 17) notes that the dependent
variable, HRQOL, S-W(179) = 0.975, p < .05, and S-W value much closer to 1.0. This
significant p-value indicated that approximation to normality was violated or the current
data was not normally distributed according to the S-W convention.
The independent variable, hope, S-W(179) = 0.937, p < .05, with an S-W value
close to 1.0 but a significant p-value, indicates that the approximation to normality was
violated. The independent variable, HPLP, S-W(179) = 0.982, p < .05, with an S-W value
closer 1.0 but a significant p-value, indicates that the approximation to normality was
violated. Overall, the results from the Shapiro-Wilk test have revealed that each of the
input variables have violated the normality assumption.
In conclusion, the sample data revealed the three input variables demonstrated to
have achieved normal distribution. According to the conventions of observed skewness
and kurtosis, values against an accepted threshold value (±1.0), and the skewness and
kurtosis ratio test were met. Although the Shapiro-Wilk’s test of normality did indicate
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violation to normality, the attained S-W values for each of the three input variables were
much closer to the value of 1.0 as a barometer of perfect normal distribution according
(Tabachnick & Fidell, 2007) standards.
Linear Assumptions. Examination of the scatterplot matrix (see Figure 7) reveals
a bivariate relationship of each of the two independent variables in Hope and HPLP. The
scatterplots also show a bivariate relationship of the moderator variable disease severity
(with five levels) to the dependent variable, HRQOL. The scatterplot matrix graph
demonstrates adequate linearity.

Figure 7. Scatterplot matrix.

Multicollinearity Assumption. Hair et al. (2010) describe multicollinearity as
when any single independent variable is highly correlated (r > .70) with a set of other
independent variables. High multicollinearity among variables lessens an individual
variable’s unique variance.
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According to Hair et al (2010), tolerance values should be above 10. Tolerance
describes the amount of an independent variable’s predictive capability that is not
predicted by other independent variables in the equation. Tolerance values less than .10
lead to multicollinearity examination. A multicollinearity test among independent
variables is called the Variance Inflation Factor (VIF). According to Field (2014), VIF
values above 5.0 are good indicators of high multicollinearity. Inspection of the
multicollinearity test (see Table 18) has revealed that independent variables in HOPE,
HPLP, and Disease Severity had observed that tolerance values and VIF values were
within the threshold standard. This indicated that problematic high correlation between
the above predictors and moderator variables were not an issue. Therefore,
multicollinearity problems between the independent variables are no concerns for this
study.
Table 18
Multicollinearity Test of Variables
Model
HPLP
HOPE
Disease
Severity

Collinearity Statistics
Tolerance
VIF
0.376
2.662
0.382
2.615
0.966

1.035

a. Dependent
Variable: QOL

Equality of Variances. Levene’s Test of Homogeneity of Variances (see Table 19)
tests whether the variances between independent groups are equal (Field, 2014). The null
hypothesis states that the variances across independent groups are equal, which indicates
that any p-values significance above a set significance level have met the assumption of

84
equal variances. Using a significance level of .05, the moderator variable with five
categorical levels/groups with p-values significance greater than the .05 level, the Levene
Statistic = 1.756, p > .05, indicates that the error variances across the five groups are
approximately equal from each other. Therefore, homogeneity of variances was assumed.

Table 19
Test of Homogeneity of Variances
QOL
Levene
Statistic

df1

df2

Sig.

1.756

4

174

0.140

Another similar test of homogeneity of variances, the test of homoscedasticity or
heteroscedasticity, is the Breusch-Pagan test of homoscedasticity. According to
Tabachnick and Fidell (2007), this test investigates whether the standardized residuals
against the predicted values are random. The Breusch-Pagan test detects any
heteroscedasticity, or whether error variances are equal between independent variables
(continuous or interval scale).

Table 20
Test of Heteroscedasticity of Variances (Breusch-Pagan Test)
Chi-Square
value
2 predictor variables (HOPE & HPLP) and
one moderator variable(Disease Severity)

2.759

Df

Sig

179

0.430

The Breusch-Pagan test of heteroscedasticity (see Table 20), using a nonsignificance value of p > .05, suggested that the error variance between the two time
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points are approximately equal from each other. Upon examination of the table, the three
independent variables had a non-significant outcome, X2 (179) = 2.759, p > .05. This
indicates that the error variances between the three independent variables are statistically
equal to each other, and therefore meets the assumption of equality of variances.
Independence of Error Terms. According to Hair et al. (2010), multiple
regression models assumed that each predicted value is independent, and that means that
the predicted value is not related to any other predicted values. Thus, values do not have a
systematic pattern that influences the predicted values from each other.
Additionally, Hair et al. (2010) recommends another diagnostic test to examine
the histogram, normal Q-Q plot, scatterplots, boxplots of the residual terms, and the
Shapiro-Wilk test of normality to determine whether non-normality of error terms are
present. This comprehensive test is the Mahalanobis Distance (D2) test, which considers
only the distance of an observation from the mean values of the independent variables
and not impact the predicted value (Hair et al., 2010). The D2 test is another way to
identify outliers.
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i. Histogram with fitted curves

iii. Boxplot

ii. Normal Q-Q Plot

iv. Scatterplot: Residual terms
by predicted values

Figure 8. Visual inspection of the residual terms (errors).

An examination of Figure 8, specifically the histogram and the boxplot, reveals
apparent symmetry of both the right and left tails of the distribution, which indicates
normality of the residual terms. No systematic pattern influences the predicted values
from each other. Even though the boxplots reveal data points outside the top and bottom
25% of the residual error scores, the normal distribution curve is not distorted. The
diagonal line of the normal Q-Q plot shows a measure of normality. Data in this plot
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points to the residual terms. Clusters above or below the line suggest that auto-correlation
of the error terms were not present in the sample data. Additionally, an examination of
the scatterplot between the residual terms and predicted values shows that the model’s
predicted values indicated random occurrences between predicted and errors. No
systematic patterns were detected. The Shapiro-Wilk test of normality (see Table 21) also
confirmed that the distribution of the residual terms are normally distributed, S-W (179) =
.989, p > 0.05.
Table 21
Test of Normality 2

Standardized
Residual

Statistic

Shapiro-Wilk
df

Sig.

0.989

179

0.197

*. This is a lower bound
of the true significance.
a. Lilliefors Significance
Correction

A Mahalanobis D (D2) test was conducted using df = 3 (2 independent variables and
1 moderator variable), and the p-value of .01 criterion at which a Chi-Square (X2) value
of 11.34 constitutes as the threshold value to determine whether such residual errors were
within acceptable limits; values greater than 11.34 indicates residual errors with nonrandom occurrences. Table 22 below had revealed 2 cases (ID# 170 and 45) and the
subsequent Mahalanobis distance values for each observation did exceed such threshold
and thus these 2 cases were excluded from the data analysis, and thus, sample size, n =
177. For model verification, a hypothesized model with the full sample (median imputed)
will be compared to the hypothesized model with 2 cases removed to verify the model’s
stability.
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Table 22
Case Summaries
ID
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
N*

Total

170
45
79
58
100
171
96
55
174
176
158
137
90
164
84
15

Mahalanobis
Distance
15.558
12.876
10.901
10.228
9.300
8.815
8.488
8.357
7.827
7.601
7.569
7.480
6.894
6.780
6.571
15

*Limited to 15 cases

Summary of Path Analysis Assumptions
In conclusion, the current sample data, along with the input variables, have
demonstrated to have met the five path analysis assumption tests of the multiple
regression model. Therefore, the path analysis was the appropriate statistical model to
estimate the overall regression and assess the direct and moderator effects of the
hypothesized model.
Research question 1. What is the level of hope in persons with Parkinson’s
disease? Persons with Parkinson’s disease identified a high level of hope. The level of
hope ranged from 16 to 48. Two cases that had significant outliers were removed. Table
24 shows the average hope scores with two cases removed (n = 177), M = 16.565 and a
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standard deviation, SD = 2.261. In other words, at one standard deviation, the spread of
hope scores range from 14.304 to 18.826. For full sample data (n = 179), hope scores had
an average, M = 16.480 and a standard deviation, SD = 2.385. At one standard deviation,
the spread of hope scores ranges from 14.095 to 18.865 at the full sample.

Analysis of Question 1. A one-sample t-test (see Table 23) shows that the
difference in hope scores between the study’s current sample data (N = 177, M = 16.565,
SD = 2.261) and the hypothesized cut-off HOPE score value (M=12.50) were statistically
significant. Statistics for the current sample test include t (176) = 23.922, p = .000, 95%
CI [3.730, 4.400] with a large effect size, Cohen’s d = 1.80 and a post-hoc statistical
power of 1.00.
For the full sample data (N = 179, M = 16.480, SD = 2.385), the difference from
hypothesized cut-off hope score value (M=12.50) were statistically significant, t (178) =
22.327, p = .000, 95% CI [3.629, 4.332]. The sample had a large effect size, Cohen’s d =
1.67 and a post-hoc statistical power of 1.00.
Table 23
One-Sample Test Hope Hypothesized Value of the Mean
Test Value = 12.50 (Hypothesized value)

HOPE(2 cases
removed)
HOPE (Full
sample)

t

df

Sig. (2tailed)

Mean
Difference

23.922

176

0.000

22.327

178

0.000

95% C.I
Lower

95% C.I.
Upper

4.065

3.730

4.400

3.980

3.629

4.332

90
Hope was also tested using the top third of the hope scale with a test value of 15.
According to Herth, some researchers using her tool have considered the lower third of
the scores as low hope and the upper third of the scores as high hope (personal
communication, February 19, 2017). The upper one third of the hope scores for the
current study’s sample was considered 15. The test value for the upper third cut off was
tested to see if the t-test for hope showed stability. The t-test for hope (two cases removed
for outliers) shows the study’s sample data (N= 177, M =1.56) (see Table 24). The upper
third cut-off increases stability, as it is statistically significant for hope, t (176) = 9.21, p
= .000, 95% CI [1.230, 1.90]. The sample had a large effect size, Cohen’s d = 1.80 and a
post-hoc statistical power of 1.00. A t-test was also completed to compare the means of
hope and gender. Females were found to have a slightly higher level of hope, M = 17.03,
SD= 2.18, versus men who had a mean level of hope, M = 16.27, SD= 2.27 (see Table
25). In addition, a correlation was run to compare hope to age. Hope did not show a
significant correlation to the participant’s age (N = 177, r = .057, p= 0.45) (see Table 26).
Table 24
One-Sample Test Hope 1/3 Cut Off
Test Value = 15 (Upper 1/3 cut off)

HOPE

t

df

Sig. (2tailed)

Mean
Difference

9.21

176

0.000

1.560

95% C.I
Lower
1.230

95% C.I.
Upper
1.900
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Table 25
Group Statistics for Hope and Gender

Gender
HOPE_Hypo1

Female
Male

Std.
Std.
Error
N
Mean Deviation Mean
69 17.0290
2.17588 .26194
108 16.2685
2.27381 .21880

Table 26
Correlations of Age
HOPE_Hypo1

Pearson
Correlation
Sig. (2tailed)
N

Age
.057
.452
177

Summary
In conclusion, the study rejected the null hypothesis for question one; there is no
difference in the level of hope between groups. There is sufficient evidence to support the
study’s assumptions. This suggests that the hope scores of the current sample population
is significantly higher compared to both the cut-off value of the hypothesized mean in the
population and the top third of the scores from the Hope scale used in this sample.
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Research question 2. What is the relationship between hope and healthpromoting behaviors on HRQOL in persons with Parkinson’s disease?

Hope

Quality of Life

Health Promoting
Behaviors

Figure 9. Conceptual diagram of the hypothesized path model.

Analysis of Question 2. Examination of Table 27 shows the average HRQOL
scores (n = 177) was, M = 28.853 and a standard deviation, SD = 6.179 with the lowest
observed minimum score, Min = 9.0 and maximum score, Max = 40.0. At one standard
deviation, the spread of QOL measure ranges from 22.674 to 35.032. The HOPE scale
had an average score, M = 16.565 and standard deviation, SD = 2.261 with the lowest
observed minimum score, Min = 11.0 and maximum score, Max = 20.0. At one standard
deviation, the spread of the HOPE measure ranges from 14.304 to 18.826. Lastly, the
HPLP scale had an average score of M = 58.729 and standard deviation of SD = 9.441,
with the lowest observed minimum score, Min = 33.0 and maximum score, Max = 83.0.
At one standard deviation, the spread of the HPLP measure ranges from 49.288 to
68.170.
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Table 27
Descriptive Statistics
N
Mean
Median
Std. Deviation
Skewness
Std. Error of
Skewness
Kurtosis
Std. Error of
Kurtosis
Minimum
Maximum

QOL
177
28.853
29
6.179
-0.512

HOPE
177
16.565
16
2.261
0.025

HPLP
177
58.729
59
9.441
-0.146

0.183

0.183

0.183

0.066

-0.944

-0.231

0.363

0.363

0.363

9
40

11
20

33
83

The hypothesized model had an observed coefficient of determination of R2 =
.620, and an Adj. R2 = .615 (see Table 28). Hope was entered first into the regression
based on the theoretical influences hope has on health-promoting behaviors. When both
explanatory variables of HOPE and HPLP were entered in the model, about 62% of the
variation of scores within the dependent measure in HRQOL was explained. Therefore,
HRQOL could be predicted by both predictor variables in the model. Overall, the
hypothesized regression model has a large effect size, which indicates that the level of
associations between the predictors and the outcome variable were large. Thus, 38% of
variance could be from factors other than the two explanatory variables presented in the
model.
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Table 28
Model Summary_________________________________________________
R Square

Adjusted
R Square

Std Error of
the Estimate

Change Statistics
R square
F
Change
Change

1

0.328

0.324

0.404

0.328

2

0.620

0.615

0.305

0.292

Model

a.

Predictor variables: Hope

b.

Predictor variables: Hope, HPLP

c.

Dependen variable: QOL

Change Statistics
Sig F
DutbinChange Watson

df1

df2

85.405

1

175

0.000

133.415

1

174

0.000

1.995

Analysis of coefficients table (see Table 29) shows that the HPLP was a
significant predictor of HRQOL while accounting for the direct effect of HOPE measure
in the model, t = 11.551, p < .001, 95% C.I. [0.553, 0.781]. The positive slope for HPLP
as a predictor of HRQOL indicated that there was a 0.667 (Beta coefficient) increase in
HRQOL measure for each increase in HPLP levels, while controlling for the effect of
HOPE measure in the model.
Using the Squared Partial Correlation, approximately 43% of the variance in
HRQOL measure was uniquely estimated by HPLP while accounting for the effect of
hope measure. Explanatory variable in hope was not a significant predictor of HRQOL
measure while accounting for the direct effect of HPLP measure in the mode, t = -1.078,
p > .05, 95% C.I. [-0.243, 0.071]. Observed statistical power of the hypothesized model
was 1.0 or 100% detection rate of avoiding a Type II error.
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Table 29
Coefficients Table
Unstandardized
Coefficients

Model

1
2

a.

Standardized
Coefficients

B

Std.
Error

(Constant)

0.675

0.211

HOPE

0.622

0.067

(Constant)

0.573

0.159

HOPE

-0.086

0.080

HPLP

0.667

0.058

t

Sig.

Beta

95.0%
Confidence
Interval for
B
Lower
Bound

Upper
Bound

3.201

0.002

0.259

1.091

9.242

0.000

0.489

0.755

3.599

0.000

0.259

0.888

-0.079

-1.078

0.282

-0.243

0.071

-0.081

0.846

11.551

0.000

0.553

0.781

0.659

0.573

Dependent variable: QOL

Lastly, comparisons between path models using a non-CFA-adjusted path model
against CFA-adjusted path model reveals the CFA adjusted remarkably improved
goodness of fit (see Table 30) of the hypothesized path model. According to Hair et al.
(2010), the lower values of Akaike Information Criterion (AIC), from 1130.165 to 86.758
and Bayesian Information Criterion (BIC) from 1142.91 to 99.46 are indicative for good
measures of model fit.

Table 30
Model Fit Comparison: Non-CFA Adjusted vs CFA Adjusted
Non-CFA adjusted Path Model
CFA adjusted Path Model
Summary

Partial

AIC
1130.165
86.758

BIC
1142.914
99.463

In conclusion, the study rejects the null hypothesis for question two; there is not a
relationship between hope, health promoting behaviors, and HRQOL. There was
sufficient evidence to support the assumption, which claims that there were at least one of

0.573
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the two explanatory variables that were statistically significant in predicting the variation
of HRQOL scores while controlling the direct effects of both explanatory variables.
HPLP was a significant predictor of HRQOL. However, HOPE was not a significant
predictor of HRQOL measure while accounting for the direct effect of HPLP (see Figure
10).

Figure 10. Final path analysis model for Hypothesis 2.

The hypothesized model had an observed coefficient of determination of R2 = .62.
This means that together, hope and HPLP explained about 62% of the variation of scores
within the dependent measure in HRQOL. Hope becomes non-significant with the
inclusion of HPLP.
Research question 3. What is the relationship among hope, health-promoting
behaviors, HRQOL, and disease severity?
Analysis of Question 3. For the path analysis, a multiple regression method used
a total of four input variables. There were two variables assigned as independent
variables, or predictors: i) HPLP = a scale variable with an interval measurement, and ii)
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HOPE = a scale variable with an interval measurement. One variable was assigned as a
moderator variable: iii) Disease Severity = a categorical variable with an ordinal
measurement (1= Stage 1, 2= Stage 2, 3 = Stage 3, 4 = Stage 4 & 5 =Stage 5). Lastly, one
criterion variable was assigned as a dependent variable; or criterion iv) HRQOL = a scale
variable with interval measurement. For the one sample t-test method, one variable was
assigned, HOPE, as the dependent variable and its median value as the test value. The
total sample size was n= 179.
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Table 31
Path Model Summary of the Multi-Group Effects

Bivariate
Correlation
of IV's

Model

Stage
1

Stage
2

Stage
3

Stage
4

Stage
5

QOL
<--HOPE
QOL
<--HPLP
QOL
<--HOPE
QOL
<--HPLP
QOL
<--HOPE
QOL
<--HPLP
QOL
<--HOPE
QOL
<--HPLP
QOL
<--HOPE
QOL
<--HPLP

Unstandardized Standardized
Coefficients
Coefficients
B

Std.
Error

Beta

-0.142

0.144

-0.141

t

Sig.

0.983

n.s.

0.695

RSquared

0.626
0.721

0.117

0.883

6.138

***

-0.222

0.227

-0.251

0.980

n.s.

0.862

0.705
0.699

0.171

1.047

4.081

***

-0.021

0.108

-0.021

0.197

n.s.

0.789

0.603
0.570

0.077

0.793

7.442

***

-0.506

0.265

-0.576

0.056
1.911

0.766

0.489
0.752

0.219

1.034

3.431

***

0.049

0.211

0.044

0.230

n.s.

0.717

0.761
0.655

0.148

0.840

4.415

***

Stage 1’s impact on the hypothesized model produced a large coefficient of
determination, R2 = 0.626, and the explanatory variable in HPLP was significant in the
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hypothesized path model, t (4, 174) = 6.138, p < .001 (see Table 31). Stage 2’s impact on
the hypothesized model also produced a large coefficient of determination, R2 = 0.705,
and the explanatory variable in HPLP was significant in the hypothesized path model, t
(4, 174) = 4.081, p < .001. Stage 3’s impact on the hypothesized model produced a large
coefficient of determination, R2 = 0.603, and the explanatory variable in HPLP was
significant in the hypothesized path model, t (4, 174) = 7.442, p < .001. Stage 4’s impact
on the hypothesized model produced a coefficient of determination, R2 = 0.489, and the
explanatory variable in HPLP was significant in the hypothesized path model, t(4, 174) =
3.431, p < .001. Finally, Stage 5’s impact on the hypothesized model produced a large
coefficient of determination, R2 = 0.761, and the explanatory variable in HPLP was
significant in the hypothesized path model, t(4, 174) = 4.415, p < .001.
A Chi-Square difference test was conducted to test whether the five stages of
disease severity moderated the direct effects between the two explanatory variables in
hope and HPLP to the criterion variable in HRQOL measure. The result from the ChiSquare test of the multi-group moderation models was not significant, X2(8) = 5.936, p =
.654. This indicated that there were no differences between the five stages of severity
given the hypothesized path model. Therefore, there was no evidence of moderating
effects of the varying stages of disease severity on the direct effects of hope and HPLP to
the criterion variable in HRQOL measure.
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Table 32
Model Fit Indices: Multi-group Moderation

GFI

AGFI
RMR
RMSEA

Acceptable Thresholds
> .95 great; > .90
traditional; > .80
permissible *
> .95 great; > .90
traditional; > .80
permissible *
< .07*
< .05 good; .05 - .10
moderate; > .10 bad*

Observed
Model Fit
0.98

0.92
0.02
0.00

*Hu and Bentler
(1999)

Table 32 is a measure of model fit using Hu and Bentler (1999) conventions of
goodness-of-fit indices. The five level multi-group moderation models appears to achieve
adequate and reasonable model fit. This confirms that hypothesized moderated model
parsimoniously fits the characteristics of the sample data.
Summary
In conclusion, the study failed to reject the null hypothesis. There is not a
relationship between hope, health promoting behaviors, and HRQOL while
controlling for disease severity. There was not sufficient evidence to support the
assumption, which claims that there were moderating effects of varying stages of disease
severity and its relation to the direct effects of hope and HPLP to the dependent measure
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in HRQOL.

Figure 11. Final path analysis model for Hypothesis 3.

The hypothesized model had an observed coefficient of determination of R2 = .67.
This means that together, hope, HPLP, and disease severity explained about 67% of the
variation of scores within the dependent measure in HRQOL. The path model suggested
that the HRQOL means between the five disease severity stages were different. However,
no difference was detected between the five disease severity stages for both hope and
HPLP. Therefore, no moderating effect of disease severity could be examined.
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CHAPTER 5: SUMMARY OF FINDINGS
Introduction
The purpose of this research was to examine the relationships between the
concepts of hope, health-promoting behaviors, and HRQOL in persons with Parkinson’s
disease. This chapter discusses the study outcomes, strengths, limitations, and
implications for nursing practice.
Summary of Findings
The participants of the study were from a convenience sample of Parkinson’s
disease support groups, the South Dakota Parkinson’s Foundation, and the Midwest
Parkinson’s Foundation mailing list. The average age of the study participant was 73
years. Sixty percent of persons in the study were male, which relates to Parkinson’s
disease being slightly higher in men than women. The majority of participants were
Caucasian and married. Over half of participants were diagnosed within the last five
years. Less than half of the participants grew up on a farm.
Research Questions. The literature and Stuifbergen’s Explanatory Model of
Health-Promotion and Quality of Life for Persons with Chronic Conditions helped
develop questions related to health-promoting behaviors, HRQOL, and disease severity.
The hope-related question was derived from nurse researcher inquiry.
Research Question 1: What is the level of hope in persons with Parkinson’s
disease? The findings of Research Question 1 were significant. The range of scores was a
minimum score of five and a maximum score of 20. The hope mean was at 16.57. The
sample mean (N = 177, M = 16.565, SD = 2.261) was statistically different and
significantly higher compared to the hypothesized population mean (M=12.50). The
upper one third of the hope scale, hope value equal to 15, was also significant, p = .000.
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Hope was noted to be significantly higher for women, but no significant difference was
noted for hope related to age. Overall, findings are substantiated that persons with
Parkinson’s disease have a high level of hope compared to both the test value of the
hypothesized population mean and the top third of the scores from the Hope scale used in
this sample.
Research Question 2: What is the relationship between hope and healthpromoting behaviors on HRQOL in persons with Parkinson’s disease? The findings
of Research Question 2 were significant. Multiple linear regression analysis identified
that hope was a statistically significant predictor variable of HRQOL. However, the
analysis found that when disease severity and health-promoting behaviors were added to
the regression, hope was no longer a statistically significant predictor of HRQOL.
This analysis identified health-promoting behaviors as a significant predictor to
HRQOL. Multiple studies by Stuifbergen established an association between healthpromoting behaviors and a strong HRQOL (Stuifbergen, 1995; Stuifbergen & Rogers,
2005; Stuifbergen, Seraphine, Harrison, & Adachi, 2004). Fowler (1997) noted a positive
relationship between hope and health-promoting behaviors in persons with Parkinson’s
disease.
Research Question 3: What is the relationship among hope, healthpromoting behaviors, HRQOL, and disease severity? The findings of Research
Question 3 were not significant (more likely due to the unequal and small sample size for
Stages 2, 4, and 5). Multiple regressions were conducted in a structural equation
modeling format. According to the path analysis, disease severity has a moderating effect
as it directly influences the relationship between hope, health-promoting behaviors, and
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HRQOL. At disease severity stage 4 of Parkinson’s disease, both hope and healthpromoting behaviors were significant predictors of HRQOL. Hope was not significant in
predicting HRQOL at the rest of the stages, but health-promoting behaviors were
predictors of HRQOL at all disease severity stages. The major drawbacks of this model
were that the sample size was small and uneven for the five stages of disease severity.
Without the inclusion of health-promoting behavior in this path model, hope is a
significant predictor of HRQOL.
According to the nursing literature, hope has a positive contribution to HRQOL
(Rustoen, 1995; Farran et al., 1995). However, when accounting for the effects of the
health-promoting behaviors in this study, hope becomes non-significant, which indicates
that health-promoting behaviors modify the relationship. This is the first study to create
an association between health-promoting behaviors, HRQOL, and hope in people with
Parkinson’s disease.
Implications for Nursing Practice
Parkinson’s disease is a health concern that is expected to double by 2030 and triple
by 2050 (NPF, 2015). The growth of this disease will impact nurses who provide care for
those with this progressive disease. Patient outcomes and HRQOL may improve if nurses
design nursing interventions to improve hope and health-promoting behaviors, which in
turn supports HRQOL. In addition, nurses have an important role to raise awareness
about gaps in resources and advocate for policy development like the Cures Law that can
help develop new treatments. Nurses can use research to collaborate with lawmakers to
work together to create legislation that benefits those with Parkinson’s disease. Nurses
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can also work with other clinicians to build evidence for funding to make devices, like a
DBS, more commonplace.
Findings for Research Question 1 pronounced the significance of hope in the lives
of persons with Parkinson’s disease. Hope is essential to the story of human life. Persons
with chronic illness are able to apply hope to overcome daily struggles and live a better
life. At the end stage of disease, hope allows persons to die with dignity. Yet nurses lack
an understanding of patients’ hope (Chi, 2007). Although hope is recognized as an
important human need, some nurses lack skills and the time needed to provide critical
emotional support. Advanced practice nurses can develop guidelines to assess hope,
maintain hope, and provide strategies to implement hope. Nurse educators can advance
the professional role of the nurse by teaching nursing students concepts of hope and hope
interventions. Nurses can collaborate with their patients to discover meaningful hopebuilding activities.
The results of Research Question 2 calls on nurses to help patients implement
health-promoting behavior strategies. Health-promoting behaviors were correlated with a
strong HRQOL. Together hope, HPLP, and disease severity explained about 67% of the
variation of scores for HRQOL. Advance practice nurses can gain insight related to
methods of health-promoting behaviors for those with Parkinson’s disease and identify
environments that lead to health-promoting behaviors. Better health-promoting behaviors
are crucial to help those with chronic illness maintain independence and quality of life
(Parcel, Barlett, Bruhm, 1986; Stuifbergen, 1995; Stuifbergen & Rogers, 2005;
Stuifbergen et al., 2004).
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The findings of Research Question 3 are pertinent to nursing practice for many
reasons. The mean for HRQOL was different based on the levels of disease severity.
However, the means for both hope and HPLP were not different, based on the levels of
disease severity. Therefore, nurses have the opportunity to implement nursing
interventions for hope and HPLP for all persons at various stages of Parkinson’s disease.
Participating in hope intervention groups has been a positive experience for persons with
cancer (Rusteon, Wiklund, Hanestad, & Moum, 1998; Herth, 2001). However, no hope
intervention program exists for persons with Parkinson’s disease. Advance practice
nurses could implement a hope intervention program for their patients in the hospital or
for persons attending support groups. The hope intervention program would be based on
strategies to improve the level of hope by doing exercises that produce hope. Herth
(2001) has used activities such as making a hope mantel, hope journaling, hope tapes,
hope drawings, hope energy saving baskets, joy collages, hope kits, hope memory books,
and other activities to engender hope.
Nurses can use patient education as an avenue to increase hope and healthpromoting behaviors. Incorporating hope-improvement strategies could be seen as part of
activities of daily living (ADLs). Nurses could add to their ADL checklist incorporate
hope strategy. This activity could be derived from surveying nurses or having focus
groups generate ideas for strategies to improve hope. Patients could also be surveyed and
asked, “Did your nurse enable hope for you today? If yes, please explain.” Exploring
features of hope related to the patient experience can help identify behaviors that
encourage attributes of hope. Similar activities could be used to incorporate health
promotion as part of daily patient education. Nurse and patient collaboration can improve

107
the level of hope and health behaviors. Advance practice nurses can research hope
strategies by asking patients and those with chronic illness questions that lead to
constructive nursing care guidelines for hope and health-promoting behavior
interventions.
Stuifbergen’s Explanatory Model of Health-Promoting Behaviors within
Chronic Conditions. The findings of this study support the conceptualization of
Stuifbergen’s Explanatory Model of Health Promoting Behaviors within Chronic
Conditions. Disease severity and hope influenced the concepts of health promotion and
quality of life. Having hope and health-promoting behaviors can help persons with
Parkinson’s disease better manage symptoms that influence quality of life.
The research findings altered the hypothesized relationships of the study variables
(see Figure 11). Hope was a statistically significant predictor variable of HRQOL.
However, when health-promoting behaviors were added to the regression, hope was no
longer a statistically significant predictor of HRQOL. Hope has a direct effect on
HRQOL, and hope also was modified when HPLP was added to the regression. Together,
hope and HPLP explained about 62% of the variation of scores within the dependent
measure in HRQOL. Health-promoting behaviors are a significant predictor to HRQOL.
There was not sufficient evidence to support the assumption, which claims that there
were moderating effects of varying stages of disease severity and its relation to the direct
effects of hope and HPLP to the dependent measure in HRQOL.
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Figure 12. New model for variables: hope, health-promoting behaviors and HRQOL.

Implications for Theoretical Framework
According to Stuifbergen & Rogers (1997), an increase in disease severity
parallels with an increase in barriers. Mobility, anxiety, depression, and pain are barriers
impacting HRQOL that the PDQ-8 measured in this study. Stuifbergen’s theory notes
that health-promoting behaviors lessen the impact severity that illness has on impairing
quality of life. Other variables that were prominent in Stuifbergen’s theory include selfefficacy, resources, and acceptance
Severity of Illness. In this study, high disease severity correlated with much
worse quality of life. The persons in the study with the highest level of disease severity
had the lowest quality of life. According to Stuifbergen’s framework, when severity of
illness increases, barriers will likely increase. Some studies suggest that having
Parkinson’s disease increases the risk of developing Lewy Body Dementia (LBD)
(Dolhun, 2015; Todorova, Jenner, & Chaudhuri, 2014). A handful of participants wrote
on the survey that they had LBD. This is the second-most progressive form of dementia
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and involves proteins, called Lewy bodies, clumping together in the brain (Mayo Clinic,
2017). The persons with LBD were noted to have high disease severity scores and low
scores on quality of life.
The results of this study partially support Stuifbergen’s theoretical model. This
study found that health-promoting behaviors were a statistically significant predictor of
HRQOL t = 11.551, p < .001, 95% C.I. [0.553, 0.781]. The results of disease severity on
HPLP is not a significant predictor of HRQOL. There was not a difference in relationship
between the five stages of disease severity on health-promoting behaviors or hope. The
result from the Chi-Square test was not significant, X2(8) = 5.936, p = .654. Therefore,
there was not moderation of the varying stages of disease severity on the direct effects of
hope and HPLP on HRQOL. Nonetheless, significant results suggested a difference for
HRQOL between the five stages of disease severity F (4, 172) = 17.821, p < .001.
Barriers. Participants with Parkinson’s disease also encountered fatigue, pain,
sleep problems, and bladder problems, which are major barriers that will increase severity
of illness and therefore decrease HRQOL (Lou, 2015; Kadastik-Eerme, Rosenthal, Paju,
Muldmaa, & Taba, 2015). Depression, anxiety, and decline in cognitive impairment in
Parkinson’s disease are possible barriers that could result in lower HRQOL (Welsch et
al., 2003).
Self-Efficacy. Health-promoting behaviors improve with self-efficacy (Strecher et
al., 1986; Stuifbergen & Becker, 1994). Self-efficacy and social cognitive theory
(Bandura, 1997) describe health promotion starting with a goal, and for a person with
Parkinson’s disease, that goal for health behavior begins with forming a lifestyle habit to
help cope with the disease. Having these good habits can help improve the quality of life.
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Resources. Stuifbergen (1995) described social support as one key resource.
People who attend support groups were the key participants in the study and made up the
majority of the population surveyed for this study. Attending a support group is a good
resource of social support. Surveying those that attend a support group may have higher
social support levels than those who did not participate in this study and are isolated from
support groups. In the rural state where the study took place, several persons may not
have access to a support group as a resource. At some of the support group meetings, the
nurse researcher noted that some attendants drove up to 45 minutes to an hour to attend.
Stuifbergen (1995) also noted income as a critical resource. A handful of persons
in this study noted that when they had undergone a DBS procedure, their quality of life
improved greatly. Hence, DBS may have lessened disease severity and had a positive
impact on HRQOL for these participants. In a meta-analysis of six randomized controlled
trials (n = 1,184), significant improvement in motor symptoms and higher quality of life
after DBS procedure was reported (Perestelo-Pérez et al., 2014). Advocating for
insurance coverage to help lessen the costs a DBS would benefit those who qualify for
this device.
Acceptance. The phase of Stuifbergen’s model before health-promoting
behaviors is acceptance. The concept is significant for people with Parkinson’s disease
because it helps with coping. Kubler-Ross (1969) describes acceptance as the last stage of
grief. Persons with Parkinson’s disease must live in the space between accepting that
there is no cure for the chronically progressive disease and the space where they hope for
a cure. For many persons with chronic diseases, this space leads to health-promoting
behaviors.
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Strengths of the Study
Theoretical definitions and frameworks guide this study. The conceptual
definition of hope created by Dufault and Martocchio’s (1985) was operationalized in the
questions of the HHI tool. The other conceptual definitions and tools relate. The study
protected against bias by having an adequate sample size of 179 persons with Parkinson’s
disease.
Instruments. Prior studies established a high amount of reliability and validity
for the three instruments used. This study also identified a high degree of reliability and
validity for the instruments. Measures of model fit for the three-factor model structure
was achieved. The robust factor model used in the study’s hypothesis testing stage was a
strength of the study.
Construct reliability of the confirmed factor structure model showed an adequate
inter-item consistency greater than the standard threshold Cronbach’s Alpha value of
0.70, HRQOL = .792, HPLP = .857, and hope = .844. The HHI is a useful tool to assess
hope in persons with Parkinson’s disease. The PDQ-8 is a useful tool to assess HRQOL
in people with Parkinson’s disease.
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Limitations of the Study
The descriptive correlational design used by this study does not report causality
but rather describes the relationships of the study variables (Polit & Beck, 2012). The size
of the sample was sufficient until it was broken down into the disease severity stages. The
sample size may be a limitation particularly related to Research Question 3, which breaks
down the sample into smaller groups based on disease severity. The non-significant
results to Research Question 3 may have been different had a larger sample been
available. A possible strong moderating effect of hope and health-promoting behaviors on
HRQOL may be noted in future studies with a larger sample.
The majority of the sample was a convenience sample of persons who participated
in support groups who were in early stages of Parkinson’s disease. Research by Herth on
hope and quality of life in persons with cancer does not measure hope in the first five
years since diagnosis of disease because the shock of new diagnosis may skew results
(Herth, 1989). Including those in this study that were recently diagnosed could be a
limitation. The sample was predominantly Caucasian, lacking ethnic diversity, which is
an additional limitation of the study. Selecting persons who were in support groups may
be a barrier to true representation of health-promoting behaviors, as these persons have
established a connection of social support. Data for health-promoting behaviors may be
skewed for this study because participants were selected from a support group and thus
are more inclined to exhibit health-promoting behaviors versus the general population.
Although evidence suggests that pesticides increase the risk of Parkinson’s
disease, this study did not find a connection between agriculture and Parkinson’s disease.
Less than half the participants were from agriculture backgrounds. However, some of the
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persons from agriculture backgrounds may have not been represented because the
majority of data collection was during the fall harvest months.
Another limitation is that persons self-report the stage of the disease, which may
misjudge the disease severity. Disease severity can lead to fatigue, and the surveys were
long, especially for persons with Parkinson’s disease who may struggle with small
handwriting. Survey fatigue is an additional limitation of this study. A possible limitation
may be having participants who had early-stage dementia and did not know it. The two
surveys that were discarded for outliers had the highest level of disease severity stage 5,
and it was noted on the survey that the participants had LBD.
The HPLP-II questionnaire was long, having 52 items. Six HPLP items were
dropped during the EFA stage because of large residual errors in order to get adequate
validity, reliability, and model fit. Survey fatigue could have contributed to limitations
of the study and problem with errors accounted for with the HPLP scale.
Recommendations for Future Study
Health-Related Quality of Life. James Parkinson’s (1817) landmark Essay on
the Shaking Palsy first noted impairments on quality of life from Parkinson’s disease 200
years ago. This classic study discovered the signs and symptoms for the disease, but
history has not yet provided a cure. Therefore, advances to increase the quality of life,
despite disease progression, are pertinent. Drug therapy has made little improvement
since the discovery of Sinemet (carbidopa-levodopa) in the early 1960s.This drug
remains the treatment of choice to improve mobility in persons with the disease.
However, this drug also causes many possible side effects, such as daytime sleepiness,
somnolence, dyskinesia, confusion, hallucinations, and compulsive behaviors (Merck
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Sharp & Dohme Corp, 2014). Taking drugs to improve motor symptoms for some
persons with Parkinson’s disease can be a double-edged sword because the side effects of
the drug can also decrease HRQOL.
Health-Promoting Behaviors Related to Nutrition. Research for a new
medicine being developed includes a possible more natural remedy using turmeric, an
herb commonly used in Indian food, as a component of a neuroprotective drug.
According to Mythri and Bharath (2012), turmeric is made of curcumin, which has great
antioxidant and anti-inflammatory effects, and contains other neuroprotective properties
that cross the blood-brain barrier. This spice has long been used as healing therapies for
not only neuroprotective, but also cardiovascular, gastrointestinal, and hepatoprotective,
and other inflammatory issues in Chinese and Ayuvedic systems of medicine
(Monograph, 2001). Future research could include a randomized control trial
implementing dietary changes to include turmeric and the effect on symptoms.
Hope and Health-Promoting Behavior Intervention Studies. Nurses can play a
significant role in influencing hope and health-promoting behaviors for persons with
Parkinson’s disease. Intervention studies to promote hope and health behaviors for
persons with Parkinson’s disease are needed. Hope interventions and health-promoting
behaviors may support HRQOL of an ongoing nature. Persons will be introduced to
concepts of hope and health-promoting behaviors as part of their daily routines. Support
groups and conferences for persons with Parkinson’s disease could be the setting for
future intervention studies.
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Conclusion
This descriptive correlational study examined the relationship between hope,
health-promoting behaviors, quality of life, and disease severity in persons with
Parkinson’s disease. Stuifbergen’s Explanatory Model of Health-Promoting Behaviors
within Chronic Conditions guided the study. Research findings from the study on hope,
health-promoting behaviors, health-related quality of life, and disease severity in persons
with Parkinson’s disease and implications for nursing practice were discussed. Strengths
and limitations of the conceptual framework were analyzed. The implications of the study
and recommendations for future studies related to hope, health-promoting behaviors, and
health-related quality of life were examined.
The study generates new nursing knowledge on hope and health-promoting
behaviors for persons with Parkinson’s disease. The study identified a relationship
between hope, health-promoting behaviors, and quality of life. These important findings
indicate that hope is beneficial to quality of life. Health-promoting behaviors are
statistically significant predictors of health-related quality of life. The increased
knowledge will raise awareness on the importance of hope and health-promoting
behaviors for persons with chronic diseases like Parkinson’s disease.
This study represents an innovative starting point for future studies implementing
hope interventions and health-promoting behaviors. Despite advancing disease severity
and the crippling effects of Parkinson’s disease, hope and health-promoting behaviors
predict quality of life. The result of hope interventions and health promoting behaviors in
persons with Parkinson’s disease is a catalyst leading to improved quality of life, not only
for those afflicted with the disease, but also their families.

116
References
Abramson, L., Alloy, L., & Metalsky, G. (1989). Hopelessness depression: A theorybased subtype of depression. Psychology Review, 96, 358–372.
doi:10.1037//0033-295x.96.2.358
Achey, M., Aldred, J., Aljeh ani, N., Bloem, B., Biglan, K., Chan, P., . . . Guttman, M.
(2014). The past, present, and future of telemedicine for Parkinson’s disease.
Movement Disorders, 29(7), 871–883.
Allen, M. T., & Levy, L. S. (2013). Parkinson’s disease and pesticide exposure: A new
assessment. Critical Reviews in Toxicology, 43(6), 515–534.
doi:10.3109/10408444.2013.798719
Amendolia, B. (2010). Hope and parents of the critically ill newborn: A concept analysis.
Advances in Neonatal Care, 10(3), 140–144.
American Nurses Association (ANA). (2015). Provision 1 code of ethics and interpretive
statements. Retrieved from http://www.nursingworld.org/provision-1
American Parkinson’s Disease Association (APDA). (2012). American Parkinson’s
Disease Association Chapter in Nebraska. Retrieved from
http://www.parkinsonsne.org/education/parkinsons-fac
Bandura, A. (1986). Social foundations of thought & action. A social cognitive theory.
Englewood Cliffs, NJ: Prentice-Hall, Inc.
Bandura, A. (1989). Regulation of cognitive processes through perceived self-efficacy.
Development Psychology, 25(5), 729–735. doi:10.1037//0012-1649.25.5.729
Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W. H. Freemen
and Company.

117
Beck, A., Rush, A., Shaw B., & Emery G. (1979). Cognitive therapy of
depression. New York, NY: Guilford.
Benight, C., & Bandura, A. (2004). Social cognitive theory of posttraumatic recovery:
The role of perceived self-efficacy. Behaviour Research and Therapy, 42, 1129–
1148. doi:10.1016/j.brat.2003.08.008
Bentler, P. (2001). EQS 6 structural equations program manual. Encino, CA:
Multivariate Software.
Bland, R., & Darlington, Y. (2002). The nature and sources of hope: Perspectives of
family caregivers of people with serious mental illness. Perspectives in
Psychiatric Care. 38(2), 61–68. doi:10.1111/j.1744-6163.2002.tb00658.x
Bluvol, A., & Ford-Gilboe, M. (2004). Hope, health work and quality of life in families
of stroke survivors. Journal of Advanced Nursing, 48(4), 322–332.
Bronk, K. Hill, P., Lapsley, D., Talib, T., & Finch, H. (2009). Purpose, hope, and life
satisfaction in three age groups. The Journal of Positive Psychology, 4, 500–510.
Bouchard, L. (1992). The relationship among eudaimonistic conception of health,
internal cancer locus of control, hope, and health-promoting lifestyle in women
with breast cancer. (Unpublished doctoral dissertation, New York University.)
Bucks, R., Cruise, K., Skinner, T., Loftus, A., Barker, R., & Thomas, M. (2011). Coping
processes and health-related quality of life in Parkinson's disease. International
Journal of Geriatric Psychiatry, 26(3), 247–255. doi:10.1002/gps.2520
Bunting-Perry, L., & Vernon, G. (2007). Comprehensive nursing care for
Parkinson's disease. New York: Springer Publishing Company.
Burns, N., & Grove, S. (2011). Understanding nursing research (5th ed.). Maryland

118
Heights, MO: Elsevier Saunders.
Businessweek. (2010). America’s fastest-growing cities. Retrieved from
www.bloomberg.com/businessweek.
Byrne, B. (2010). Structural equation modeling with AMOS (2nd ed.). Routledge,
UK.
Caap-Ahlgren, M., & Lannerheim, L. (2002) Older Swedish women’s experiences of
living with symptoms related to Parkinson’s disease. Journal of Advanced
Nursing, 39(1), 87–95.
Cantrell, M., & Lupinacci, P. (2004). A predictive model of hopefulness for adolescents
Journal of Adolescent Health, 35, 478–485.
Canty-Mitchell, J. (2001). Life change events, hope, and self-care agency in inner-city
adolescents. Journal of Child and Adolescent Psychiatric Nursing, 14, 18–31.
Carvajal, S., Clair, S., Nash, S., & Evans, R. (1998). Relating optimism, hope, self
esteem to social influences in deterring substance use in adolescents. Journal of
Social and Clinical Psychology, 17, 443–465.
Center for Disease Control (CDC). (2015). Health-related quality of life. Retrieved from
http://www.cdc.gov/hrqol/
Chi, G. (2007). The role of hope in patients with cancer. Oncology Nursing Forum, 34(2),
415-424. doi:10.1188/07.ONF.415-424
City-Data.com. (2014). Stats about U.S. cities. Retrieved from http://www.city-data.com.
College of Public Health. (2013). What is health promotion and behavior? Retrieved from
http://www.publichealth.uga.edu/hpb/what-health-promotion-behavior
Dillman, D., Christian, L., & Smyth, J. (2014). Internet, phone, mail, and mixed-mode
surveys: The tailored design method (4th ed.). Hoboken: Wiley.

119
Dolhun, R. (2015). Ask the MD: FAQs on Lewy Body Dementia. Retrieved from
https://www.michaeljfox.org/foundation/news-detail.php?ask-the-md-faqs-onlewy-body-dementia
Dorcy, K. (2010). Hegemony, hermeneutics, and the heuristic of hope. Advances in
Nursing Science, 33(1), 78–90.
Dowding, C., Shenton, C., & Salek, S. (2006). A review of the health-related quality of
life and economic impact of Parkinson’s disease. Drugs Aging, 23, 693–721.
Dufault, K., & Martocchio, B. C. (1985). Hope: Its spheres and dimensions. Nursing
Clinics of North America, 20, 379–391.
Duffy, M. (1993). Determinants of health-promoting lifestyles in older persons.
Image: The Journal of Nursing Scholarship, 25, 23–28.
Duggleby, W., Holtslander, L., Kylma, J., Duncan, V., Hammond, C., & Williams, A.
(2010). Metasynthesis of the hope experience of family caregivers of persons with
chronic illness. Qualitative Health Research, 20(2), 148–158.
Edwards, L., Ong, A., & Lopez, S. (2007). Hope measurement in Mexican America
youth. Hispanic Journal of Behavioral Sciences, 29, 225–241.
Erikson, E. H. (1964). Childhood and society (2nd ed.). New York: W.W. Norton
Falce, A. (2016). The 21st Century Cure Act and Parkinson’s disease. The Michael J. Fox
Foundation for Parkinson’s Research. Retrieved from
https://www.michaeljfox.org/foundation/news-detail.php?the-21st-century-curesact-and-parkinson-disease
Farran, C., Herth, K., & Popovich, J. (1995). Hope and hopelessness: Critical clinical
constructs. Sage Publications, Inc.

120
Farran, C., Salloway, J., & Clark, D. (1990). Measurement of hope in a community-based
older population. Western Journal of Nursing Research, 12, 42–59.
Fereshtehnejad, S. Naderi, N., Rahmani, A., Shahidi, G., Delbari, A., & Lökk, J. (2014).
Psychometric study of the Persian short-form eight-item Parkinson's disease
questionnaire (PDQ-8) to evaluate health-related quality of life (HRQOL). Health
& Quality of Life Outcomes, 12(1), 1–18. doi:10.1186/1477-7525-12-78
Field, A. (2014). Discovering statistics using SPSS (4th ed.). Beverly Hills: Sage
Publications Ltd.
Findley, L. (2002). Factors impacting on quality of life in Parkinson’s disease: Results
from an international survey. Movement Disorders, 17(1), 60–67.
Frankl, V. (1959). Man’s search for meaning. Boston, MA: Beacon Press.
Forbes S. (1994). Hope: An essential human need in the elderly. Journal of
Gerontological Nursing, 20, 5–10.
Fowler, S. (1997). Hope and a health-promoting lifestyle in persons with Parkinson’s
disease. Journal of Neuroscience Nursing, 29(2), 111–116.
Gage, H., Hendricks, A., Zhang, S., & Kazis, L. (2003). The relative health related
quality of life of veterans with Parkinson’s disease. Journal of Neurology,
Neurosurgery & Psychiatry, 74(2), 163–169.
Gaskin, J., (2012). Factor analysis. From Gaskination’s Stat Wiki. Retrieved from
http://statwiki.kolobkreations.com/
Gatto, N., Cockburn, M., Bronstein, J., Manthripragada, A., & Ritz, B. (2009).

121
Well-water consumption and Parkinson's disease in rural California.
Environmental Health Perspectives, 117(12), 1912–1918.
doi:10.1289/ehp.0900852
Gilman, R., Dooley, J., & Florell, D. (2006). Relative levels of hope and their
relationship with academic and psychological indicators among adolescents.
Journal of Social and Clinical Psychology, 25,166–178.
Glanz, K., & Maddock, J. (2002). Behavior, health-related. Gale Encyclopedia of Public
Health. Gale Group, Inc.
Global Parkinson’s Disease Survey Steering Committee. (2002). Factors impacting
quality of life in Parkinson’s disease. Results from an international survey.
Movement Disorders, 17, 60–67.
Goetz, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.., Counsell, C., ... & Yahr,
M. D. (2004). Movement Disorder Society Task Force report on the Hoehn and
Yahr staging scale: Status and recommendations the Movement Disorder Society
Task Force on rating scales for Parkinson's disease. Movement Disorders, 19(9),
1020–1028.
Green, M. (1977). Anticipation, hope, and despair. Journal of American Academy of
Psychoanalysis, 5(2), 215–232.
Gwinn, K. (2009). Genetics and Parkinson’s disease: What have we learned? Parkinson’s
Disease Foundation. Retrieved from
http://www.pdf.org/en/genetics__parkinsons_gwinn
Haahr, A., Kirkevold, M., Hall, E., & Ostergaard, K. (2011). Living with advanced

122
Parkinson’s disease: A constant struggle with unpredictability. Journal of
Advanced Nursing, 67(2), 408–417. doi:10.1111/j.1365-2648.2010.05459.x
Hair, J., Black, W., Babin, B., & Anderson, R. (2010). Multivariate data
Analysis (7th ed.). Pearson Prentice Hall.
Harrison, R. (1993). The relationship among hope, perceived health status and healthpromoting lifestyle among HIV seropositive men. UMI Dissertation Services.
Health Promoting Behavior. (2013). Medical Dictionary. Retrieved from
http://medicaldictionary.thefreedictionary.com/health+promoting+behavior
Heaven, P., & Ciarrochi, J. (2007). Personality and religious values among adolescents:
A three-wave longitudinal analysis. British Journal of Psychology, 98, 681–694.
Hexdall, C., & Huebner, S. (2007). Subjective well-being in pediatric oncology patients.
Applied Research in Quality of Life, 2, 189–208.
Herth. K. (1989). The relationship between level of hope and coping response and other
variables in patients with cancer. Oncology Nursing Forum. 16(1), 67–72.
Herth, K. (1992). Abbreviated instrument to measure hope: Development and
psychometric evaluation: The Herth Hope Index. Journal of Advanced Nursing,
17(10), 1251–1259. doi:10.1111/j.1365-2648.1992.tb01843.x
Herth, K. (1993). Hope in the family caregiver of terminally ill people. Journal of
Advanced Nursing, 17, 1251–1259.
Herth, K. (2000). Enhancing hope in people with a first recurrence of cancer. Journal of
Advanced Nursing, 32(6), 1431–1441.
Hoehn, M., & Yahr, M. (1967). Parkinsonism: Onset, progression and mortality.
Neurology, 17, 427–442.

123
Hu, L., & Bentler, P. (1999). Fit indices in covariance structure modeling: Sensitivity to
underparameterized model misspecification. Psychological Methods, 3(4), 424–
453.
Jenkinson, C., & Fitzpatrick, R. (2007). Cross-cultural evaluation of the short form 8
-item Parkinson’s Disease Questionnaire (PDQ-8): Results from America,
Canada, Japan, Italy and Spain. Parkinsonism Related Disorders, 13(1), 22–28.
doi:http://dx.doi.org/10.1016/j.parkreldis.2006.06.006
Jenkinson, C., Fitzpatrick, R., Norquist, J., Findley, L., & Hughes, K. (2003). Cross
cultural validation of the Parkinson’s disease questionnaire: Tests of data quality,
score reliability, response rate and scaling assumptions in America, Canada,
Japan, Italy and Spain. Journal of Clinical Epidemiology, 56, 43–47.
Johnson, R. (2005). Gender differences in health-promoting lifestyles of African
Americans. Public Health Nursing, 22, 130–137.
Jones, C., Pohar, S., & Patten, S. (2009). Major depression and health-related quality of
life in Parkinson’s disease. General Hospital Psychiatry, 31(4), 334–340.
doi:10.1016/j.genhosppsych.2009.03.009
Kadastik-Eerme, L., Rosenthal, M., Paju, T., Muldmaa, M., & Taba, P. (2015). Healthrelated quality of life in Parkinson’s disease: A cross-sectional study focusing on
non-motor symptoms. Health & Quality of Life Outcomes, 13(1), 1–8.
doi:10.1186/s12955-015-0281-x
Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M. C., Blair, A., & Sandler, D.
(2007). Pesticide exposure and self-reported Parkinson’s disease in the
Agricultural Health Study. American Journal of Epidemiology, 165(4), 364–374.

124
Kenborg, L., Lassen, C., Lander, F., & Olsen, J. (2012). Parkinson’s disease among
gardeners exposed to pesticides: A Danish cohort study. Scandinavian Journal of
Work, Environment & Health, 38(1), 65–69. doi:10.5271/sjweh.3176
Kemppainen, V., Tossavainen, K., & Turunen, H. (2012). Nurses’ role in health
promotion practice: An integrative review. Health Promotion International,
28(4), 490–501. doi:10.1093/heapro/das034
Kim, D., Moon, W., Ahn, S., Oh, H., Kwan, K., Park, M., et al. (2004). Meta-analysis of
the research findings concerning functional relationships of explanatory variables
to hope. Cancer Nursing, 34, 673–684.
King, P. (1994). Health promotion: The emerging frontier in nursing. Journal of
Advanced Nursing, 20, 209–218.
Leonardi, M., Raggi, A., Pagani, M., Carella, F., Soliveri, P., Albanese, A., & Romito, L.
(2012). Relationships between disability, quality of life and prevalence of
nonmotor symptoms in Parkinson's disease. Parkinsonism Related Disorders,
18(1), 35–39. doi:10.1016/j.parkreldis.2011.08.011
Lieberman, M., & Tobin, S. (1983). The experience of old age: Stress, coping, and
Survival. Basic Books.
Liu, H., Ling, X., Feng, M., Guo, Y., & Chen, M. (2009). Responses, actions and healthpromoting behavior among rural Taiwanese women with abnormal Papanicolaou
test. Public Health Nursing, 26(2), 134–143.
doi:10.1111/j.1525-1446.2009.00764.x
Lohne, V., & Severinsson, E. (2004). Hope during the first months after acute spinal cord
injury. Journal of Advanced Nursing, 47(3), 279–286.

125
Lorig, K., Sobel, D. S., Stewart, A., Brown, B., Jr., Bandura, A., Ritter, P. . . .
Holman, H. (1999). Evidence suggesting that a chronic disease selfmanagement program can improve health status while reducing hospitalization: A
randomized trial. Medical Care, 37(1), 5–14.
Lou, J.-S. (2015). Fatigue in Parkinson’s disease and potential interventions.
Neurology Rehabilitation, 37(1), 25–34. 10p. doi:10.3233/NRE-151238
Lynch. (1965). Images of hope: Imagination as healer of the
hopeless. United States. Garamond/Pridemark Press.
Mahat, G., & Scoloveno, M. A. (2001). Factors influencing health practices of Nepalese
adolescent girls. Journal of Pediatric Health Care, 15, 251–255.
Mahat, G., Scoloveno, M. & Whelan, C. (2002). Positive health practices of urban
minority adolescents. The Journal of School Nursing, 18, 163–169.
Mahon, N., Yarcheski, A., & Yarcheski, T. J. (2004). Social support and positive health
practices in early adolescents: A test of mediating variables. Clinical Nursing
Research, 13, 216–236.
Manthorpe, J., Iliffe, S., Samsi, K., Cole, L., Goodman, C., Drennan, V., & Warner, J.
(2010). Dementia, dignity and quality of life: Nursing practice and its dilemmas.
International Journal of Older People Nursing, 5(3), 235–244.
doi:10.1111/j.1748-3743.2010.00231.x
Marder K., Logroscino G., Alfaro B., Mejia H., Halim A., & Louis E. (1998).
Environmental risk factors for Parkinson’s disease in an urban multiethnic
community. Neurology, 50(1), 279–281.
Marriner-Tomey, A., & Alligood, M. R. (2010). Nursing theorists and their work.

126
Elsevier Health Sciences.
Marinus, J., Ramaker, C., Hilten, J., & Stiggelbout, A. (2002). Health-related quality of
life in Parkinson’s disease: A systematic review of disease specific instruments.
Journal of Neurology Neurosurgery Psychiatry, 72, 241–248.
Mayo Clinic. (2017). Lewy body dementia overview. Retrieved from
http://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/home/ovc20200344
McCutcheon, T. (2015). Concept analysis: Health-promoting behaviors related to
human Papilloma Virus (HPV) Infection. Nursing Forum, 50(2), 75–82.
doi:10.1111/nuf.12094
McWilliam, C., Stewart, M., Brown, J., Desai, K., & Coderre, P. (1996). Creating
health with chronic illness. Advances in Nursing Science, 18(3), 1–15.
Medtronic. (20009). DBS therapy for Parkinson’s disease and essential tremor clinical
Summary. Retrieved from http://www.medtronicdbs.com/essentialtremor/about/common-questions/
Meraviglia, M., Stuifbergen, A., Parsons, D., & Morgan, S. (2013). Health promotion for
cancer survivors: Adaptation and implementation of an intervention. Holistic
Nursing Practice, 27(3), 140–147. doi:10.1097/HNP.0b013e31828a0988
Merck Sharp & Dohme Corporation. (2014). Sinemet (carbidopa levodopa) Tablets.
Retrieved from
https://www.merck.com/product/usa/pi_circulars/s/sinemet/sinemet_pi.pdf
Miller, G., & Foster, L. (2010). Critical synthesis of the wellness literature. British
Columbia Atlas of Wellness. Retrieved from http://www.geog.uvic.ca/wellness

127
Miller, L., & Kelley, B. (2005). Relationships of religiosity and spirituality with mental
health and psychopathology. In R. F. Paloutzian & C. L. Park (Eds.), Handbook of
the psychology of religion and spirituality (pp. 460–478). New York: The
Guilford Press.
Miyashita, M., Narita, Y., Sakamoto, A., Kawada, N., Akiyama, M., Kayama, M., &
Fukuhara, S. (2011). Health-related quality of life among community-dwelling
patients with intractable neurological diseases and their caregivers in Japan.
Psychiatry and Clinical Neuroscience, 65(1), 30–38. doi:10.1111/j.14401819.2010.02155.x
Monograph. Curcuma longa (tumeric). (2001). Alternative Medicine Review, 6, S62–66.
Morano A, Jimenez-Jimenez F., Molina J., & Antolin M. (1994). Risk-factors for
Parkinson’s disease: Case-control study in the province of Caceres, Spain. Acta
Neurologica Scandinavica. 89(3),164–170.
Munro, B. (2005). Statistical methods for health care research (5th ed.). Philadelphia,
PA: Lippincott Williams & Wilkins.
Mythri, R., & Bharath, M. (2012). Curcumin: A potential neuroprotective agent in
Parkinson’s disease. Current Pharmaceutical Design, 18(1), 91–99.
doi:http://dx.doi.org/10.2174/138161212798918995
National Parkinson’s Foundation (NPF). (2015). About us. Retrieved from
http://www.parkinsons.org/About-Us
Nelson, N., Wong, D., & Lai, E. (2011). A self-management program for veterans and
spouses living with Parkinson's disease. Journal of Nursing & Healthcare of
Chronic Illnesses, 3(4), 496-503. doi:10.1111/j.1752-9824.2011.01125.x

128
Owens, K. (2008). Pesticides trigger Parkinson’s disease. Pesticides and You, 28(1), 14–
20.
Parcel G., Barlett, E., & Bruhn, J. (1986) The role of health education in selfmanagement. In Self-management of chronic disease (K. A. Holroyd & T. L.
Creer, eds), Academic Press, Orlando, FL, pp. 3–27.
Parkinson’s Disease Foundation (PDF). (2016). Statistics on Parkinson’s. Retrieved from
http://www.pdf.org/en/parkinson_statistics
Parkinson’s disparities. (2010, December 13). Science Daily. Retrieved from
http://www.sciencedaily.com/releases/2010/12/101213163807.htm
Parkinson, J. (1817). Essay on the shaking palsy. London: Neely and Jones.
Pelligrino, E. (2008). The lived experience of human dignity. In Human dignity
and bioethics: Essays commissioned by the President’s Council on bioethics (pp.
513–539). Washington, DC: Government Printing Office.
Pender, N. (1987). Health promotion in nursing practice (2nd ed.). Norwalk, Conn:
Appleton & Lange.
Pender, N. (2011). Health promotion model manual. Retrieved from
https://deepblue.lib.umich.edu/bitstream/handle/2027.42/85350/HEALTH_PROM
OTION_MANUAL_Rev_5-2011.pdf?sequence=1&isAllowed=y
Pender, N., Barkauskas, V., Hayman, L., Rice, V., & Anderson, E. (1992). Health
promotion and disease prevention: Toward excellence in nursing practice and
education. Nursing Outlook, 40, 106–112.
Pender, N. Murdaugh, C., & Parsons, M. (2015). Health promotion in nursing practice

129
(7th ed). Upper Saddle River, N.J.: Prentice Hall.
Perestelo-Pérez, L., Rivero-Santana, A., Pérez-Ramos, J., Serrano-Pérez, P., Panetta, J.,
& Hilarion, P. (2014). Deep brain stimulation in Parkinson's disease: Metaanalysis of randomized controlled trials. Journal of Neurology, 261(11), 20512060. doi:10.1007/s00415-014-7254-6
Polit, D., & Beck, C. (2012). Nursing research: Generating and assessing evidence
for nursing practice (9th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
Povlsen, L., & Borup, I. (2011). Holism in nursing and health promotion: Distinct or
related perspectives?: A literature review. Scandinavian Journal of Caring
Science, 25(4), 798–805. doi:10.1111/j.1471-6712.2011.00885.x
Portney, L., & Watkins, M. (2009). Foundations of clinical research applications to
practice (3rd ed.). Upper Saddle River, NJ: Pearson Education, Inc.
Post, B., Muslimovic, D., van Geloven, N., Speelman, J., Schmand, B., & de Haan, R.
(2011). Progression and prognostic factors of motor impairment, disability and
quality of life in newly diagnosed Parkinson's disease. Movement Disorders,
26(3), 449–456. doi:10.1002/mds.23467
Qin, Z., Zhang, L., Sun, F., Fang, X., Meng, C., Tanner, C., & Chan, P. (2009). Health
related quality of life in early Parkinson's disease: Impact of motor and non-motor
symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Related
Disorders, 15(10), 767–771. doi:10.1016/j.parkreldis.2009.05.011
Ritchie, M. (2001). Self-esteem and hopefulness in adolescents with cancer. Journal
of Pediatric Nursing, 16, 35–42.
Rodriguez-Violante, M., Cervantes-Arriaga, A., Corona, T., Martinez-Ramirez, D.,

130
Morales- Briceno, H., & Martinez-Martin, P. (2013). Clinical determinants of
health-related quality of life in Mexican patients with Parkinson's disease.
Archives of Medical Research, 44(2), 110–114. doi:10.1016/j.arcmed.2013.01.005
Roesch, S., Duangado, K., Vaughn, A., Aldridge, A., & Villodas, F. (2010).
Dispositional hope and the propensity to cope: A daily diary assessment of
minority adolescents. Cultural Diversity & Ethnic Minority Psychology, 16(2),
191–198.
Rustoen, T. (1995). Hope and quality of life, two central issues for cancer patients: A
theoretical analysis. Cancer Nursing, 18, 355–361.
Rusteon, T., Wiklund, I., Hanestad, B., & Moum, T. (1998). Nursing intervention to
increase hope and quality of life in newly diagnosed cancer patients. Cancer
Nursing, 21, 235–245.
Ruth, M. (2015). Health promotion. Salem Press. Retrieved from
http://www.salempress.com/salem_health.html
Savage, C., & Kub, J. (2009). Public health and nursing: A natural partnership.
International Journal of Environmental Research and Public Health, 6(11),
2843–2848. doi:10.3390/ijerph6112843
Schrag A. (2006). Quality of life and depression in Parkinson's disease.
Journal of Neurological Sciences, 248, 151–157.
Schreurs, K., De Ridder, D., & Bensing, J. (2000). A one year study of coping, social
support and quality of life on Parkinson’s disease. Psychology & Health, 15(1),
109–121.
Shimbo, T., Goto, M., Morimoto, T., Hira, K., Takemura, M., Matsui, K., … Fukui, T.

131
(2004). Association between patient education and health-related quality of life in
patients with Parkinson’s disease. Quality of Life Research, 13(1), 81–89.
Sigstad, H., Stray-Pedersen, A., & Froland, S. (2005). Coping, quality of life, and
hope in adults with primary antibody deficiencies. Health Qualitative Life
Outcomes, 3, 31. doi:10.1186/1477-7525-3-31
Shoegren, K., Lopez, S., Wehmeyer, M., Little, T., & Pressgrove, C. (2006).
The role of positive psychology constructs in predicting life satisfaction in
adolescents with and without cognitive disabilities: An exploratory study. The
Journal of Positive Psychology, 1, 37–52.
Simon, K., Barakat, L., Patterson, C., & Dampier, C. (2009). Symptoms of
depression and anxiety in adolescents with sickle cell disease: The role of
intrapersonal characteristics and stress producing variables. Child Psychiatry and
Human Development, 40, 317–330.
Simpson, C. (2004). When hope makes us vulnerable: A discussion of patient–healthcare
provider interactions in the context of hope. Bioethics, 18(5), 428–447.
Smargiassi, A., Mutti, A., DeRosa, A., DePalma, G., Negrotti, A., & Calzetti, S. (1998).
A case-control study of occupational and environmental risk factors for
Parkinson’s disease in the Emilia-Romagna region of Italy. Neurotoxicology,
19(4–5), 307–311.
South Dakota Parkinson’s Foundation. (2015). SD Parkinson’s awareness newsletter,
15(2), 1.
Strecher, V., DeVellis, B., Becker, M., & Rosenstock, I, (1986). The role of self-efficacy
in achieving health behavior change. Health Education Quarterly, 13(1). 73–91.

132
Stuifbergen, A. (1995). Health promoting behaviors and quality of life among individuals
with multiple sclerosis. Scholarly Inquiry of Nursing Practice, 9 (1), 31–50.
Stuifbergen, A., & Becker, H. (1994). Predictors of health promoting lifestyles in persons
with disabilities. Research in Nursing and Health, 17, 3–13.
Stuifbergen A, Harrison, T., Becker, H., & Carter, P. (2004). Adaptation of a wellness
intervention for women with chronic disabling conditions. Journal of Holistic
Nursing, 22(1), 12–31.
Stuifbergen, A., & Rogers, S. (1997). Health promotion: An essential component of
rehabilitation for persons with chronic disabling conditions. Advances in Nursing
Science, 19, 1–20.
Stuifbergen, A., Seraphine, A., Harrison, T., & Adachi, E. (2005). An explanatory model
of health promotion and quality of life for persons with post-polio syndrome.
Social Science & Medicine, 60(2), 383–393.
Stuifbergen, A., Seraphine, A., & Roberts, G. (2000). An explanatory model of healthpromoting behavior and quality of life for persons with chronic disabling
conditions. Nursing Research, 49(3), 122–129.
Tabachnick, B. & Fidell, L. (2007). Using multivariate statistics (5th ed.). Boston: Allyn
and Bacon.
Tan, L., Luo, N., Nazri, M., Li, S., & Thumboo, J. (2004). Validity and reliability of the
PDQ 39 and the PDQ-8 in English speaking Parkinson’s disease patients in
Singapore. Parkinsonism Related Disorders, 10, 493–499.
Tengland, P. (2010). Health promotion or disease prevention: A real difference for public
health practice? Health Care Analysis, 18(3), 203–221. doi:10.1007/s10728-009-

133
0124-1
Tinsley, E., & Brown, S. (2000). Applied multivariate statistics and mathematical
modeling. Burlington: Elsevier.
Todorova, A., Jenner, P., & Chaudhuri, K. (2014). Non-motor Parkinson’s: Integral to
motor Parkinson’s, yet often neglected. Practicing Neurology, 14(5), 310–322.
doi:10.1136/practneurol-2013-000741
Travelbee, J. (1971). Interpersonal aspect of nursing. Philadelphia, PA: F.A. Davis.
Tremblay, M., & Richard, L. (2011). Complexity: A potential paradigm for a health
promotion discipline. Health Promotion International, 29(2), 378–388.
doi:10.1093/heapro/dar054
U.S. Census Bureau. (2014). South Dakota Quick Facts. Retrieved from
http://www.census.gov/quickfacts/download.php?fips=46
U.S. Census Bureau. (2015). South Dakota Quick Facts. Retrieved from
http://www.census.gov/quickfacts/table/PST045215/4652980
U.S. Department of Health and Human Services. (2012). Developing healthy people
2020. Retrieved from
http://www.healthypeople.gov/hp2020/Objectives/TopicArea.aspx?id=37&Topic
Area=older%20Adults
Vacek, K., Coyle, L., & Vera, E. (2010). Stress, self-esteem, hope, optimism, and wellbeing in urban ethnic minority adolescents. Journal of Multicultural Counseling
and Development, 38, 99–111.
Valle, M., Huebner, E., & Suldo, S. (2006). An analysis of hope as a psychological
strength. Journal of School Psychology, 44, 393–406.

134
Van Den Eeden, S., Tanner, C., Bernstein, A., Fross, R., Leimpeter, A.,
Bloch, D., & Nelson, L. (2003). Incidence of Parkinson’s disease: Variation
by age, gender, and race/ethnicity. American Journal of Epidemiology, 157(11),
1015–1022.
Visser, M., Verbaan, D., van Rooden, S., Marinus, J., van Hilten, J., & Stiggelbout, A.
(2009). A longitudinal evaluation of health-related quality of life of patients with
Parkinson’s disease. Value Health, 12(2), 392-396. doi:10.1111/j.15244733.2008.00430.x
Walker, S., Sechrist, K., & Pender, N. (1987). The health-promoting lifestyle profile:
Development and psychometric characteristics. Nursing Research, 36, 76–81.
Walker, S., & Hill-Polerecky, D. (1996). Psychometric evaluation of HPLP
II. Unpublished Manuscript, University of Nebraska Medical Center.
Wang, W., Fang, X., Cheng S., Jiang, D., & Lin Z. (1993). A case-control study on the
environmental risk factors of Parkinson’s disease in Tianjin, China.
Neuroepidemiology, 12(4), 209–218.
Warner, R. (2013). Applied statistics: From bivariate through multivariate techniques
(2nd ed.). Thousand Oaks, CA: Sage Publications.
Watson, J. (2012). Nursing theories: A companion to nursing theories and models.
Retrieved from http://currentnursing.com/nursing_theory/Watson.html
Weintraub, D., Moberg, P., Duda, J., Katz, I., & Stern, M. (2004). Effect of
psychiatric and other nonmotor symptoms on disability in Parkinson’s disease.
Journal of the American Geriatrics Society, 52(5), 784–788.
doi:10.1111/j.1532-5415.2004.52219

135
Welsch, M., McDermott, M, Holloway, R., Plumb, S., Pfeiffer, R. & Hubble, J. (2003).
Parkinson’s study group, development and testing of the Parkinson’s disease
quality of life scale. Movement Disorders, 18(6), 637–645.
Wechsler L., Checkoway H, Franklin G., & Costa L. (1991). A pilot study of
occupational and environmental risk factors for Parkinson’s disease.
Neurotoxicology, 12(3), 387–392.
Williams, B. (2012). Exploratory factor analysis: A five step guide. Australasian Journal
of Paramedicine, 8(3).
Whitehead, D. (2001). Health education, behavioural change and social psychology:
Nursing’s contribution to health promotion. Journal of Advanced Nursing, 34,
822–832.
Whitehead, D. (2004). Health promotion and health education: Advancing the concepts.
Journal of Advanced Nursing, 47, 311–320.
Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R., & Racette, B. A. (2010).
Geographic and ethnic variation in Parkinson’s disease: A population-based study
of US Medicare beneficiaries. Neuroepidemiology, 34(3), 143–151.
doi:10.1159/000275491
Wilson M. (2005). Health-promoting behaviours of sheltered homeless women.
Family & Community Health, 28, 51–63.
Winter, Y., von Campenhausen, S., Gasser, J., Seppi, K., Reese, J. P., Pfeiffer, K. P., . . .
Poewe, W. (2010a). Social and clinical determinants of quality of life in
Parkinson’s disease in Austria: A cohort study. Journal of Neurology, 257(4),
638–645. doi:10.1007/s00415-009-5389-7
Winter, Y., von Campenhausen, S., Popov, G., Reese, J. P., Balzer-Geldsetzer, M.,

136
Kukshina, A., Guekht, A. (2010b). Social and clinical determinants of quality of
life in Parkinson’s disease in a Russian cohort study. Parkinsonism Related
Disorders, 16(4), 243–248. doi:10.1016/j.parkreldis.2009.11.012
Winter, Y., von Campenhausen, S., Arend, M., Longo, K., Boetzel, K., Eggert, K., . . .
Barone, P. (2011). Health-related quality of life and its determinants in
Parkinson's disease: Results of an Italian cohort study. Parkinsonism Related
Disorders, 17(4), 265–269. doi:10.1016/j.parkreldis.2011.01.003
Wong, G., Gray C., Hassanein R., & Koller W. (1991). Environmental risk factors in
siblings with Parkinson’s disease. Archives of Neurology. 48(3):287–289.
Wong, S., & Lim, T. (2009). Hope versus optimism in Singaporean adolescents:
Contributions to depression and life satisfaction. Personality and Individual
Differences, 46, 648–652
World Health Organization (WHO). (2015). Health topics: Health promotion. Retrieved
from http://www.who.int/topics/health_promotion/en/
Wressle, E., Bringer, B., & Granérus, A. (2006). Quality of life in Parkinson's disease at a
geriatric outpatient department in Sweden. International Journal of Therapy &
Rehabilitation, 13(8), 365–369.
Yarcheski, M., Mahon, N. & Yarcheski. T. (2001). Social support and well-being in early
adolescents: The role of mediating variables. Clinical Nursing Research, 10,163–
181.

137
Appendix A
Demographic instrument for background information
1. Participant age _________
2. Gender:
_____Male
_____Female
3. Marital status
_____Single, never married
_____Married
_____Divorced
_____Separated
_____Widowed
_____In a relationship, but not married
4. Ethnicity
_____White
_____Native American
_____Hispanic
_____Asian-Pacific Islander
_____African American
5. Length of time since diagnosis____________
6. Did you grow up on a farm/ranch?
______Yes
______No
7. Length of time on a farm/ranch_________
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Appendix B
Hoehn and Yahr Stages of Parkinson’s Disease Scale
Stage 01

Symptoms on one side only

Stage 02

Symptoms on both sides without balance
impairment

Stage 03

Mild to moderate disease, some postural
instability, physically independent

Stage 04

Severe disease, able to walk or stand
unassisted

Stage 05

Wheelchair bound or bedridden unless
assisted

The following statement best describes my symptoms, when I feel at my best: (check
one)
q1 I have symptoms on the one side of my body only
q2 I have symptoms on both sides of the body, but my balance is not affected
q3 I have mild to moderate symptoms on both sides of the body, and my balance is
somewhat affected, but I am physically independent
q4 My symptoms are severe, but I am still able to stand and walk without help
q5 I cannot get out of the bed or up from a chair unless somebody helps me
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Appendix C
Health-Promoting Lifestyle Profile (HPLP) II

DIRECTIONS: This questionnaire contains statements about your present way of life or personal habits. Please respond to each item
as accurately as possible, and try not to skip any item. Indicate the frequency with which you engage in each behavior by circling:

ROUTINELY

OFTEN

SOMETIMES

NEVER

N for never, S for sometimes, O for often, or R for routinely

1.

Discuss my problems and concerns with people close to me.

N

S

O

R

2.

Choose a diet low in fat, saturated fat, and cholesterol.

N

S

O

R

3.

Report any unusual signs or symptoms to a physician or other health professional. N

S

O

R

4.

Follow a planned exercise program.

N

S

O

R

5.

Get enough sleep.

N

S

O

R

6.

Feel I am growing and changing in positive ways.

N

S

O

R

7.

Praise other people easily for their achievements.

N

S

O

R

8.

Limit use of sugars and food containing sugar (sweets).

N

S

O

R
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9.

Read or watch TV programs about improving health.

N

S

O

R

10. Exercise vigorously for 20 or more minutes at least three times a week (such as

N

S

O

R

walking,
aerobic
dancing,
11. brisk
Take some
timebicycling,
for relaxation
each
day. using a stair climber).

N

S

O

R

12. Believe that my life has purpose.

N

S

O

R

13. Maintain meaningful and fulfilling relationships with others.

N

S

O

R

14. Eat 6-11 servings of bread, cereal, rice and pasta each day.

N

S

O

R

15. Question health professionals in order to understand their instructions.

N

S

O

R

16. Take part in light to moderate physical activity (such as sustained walking 30-40 N

S

O

R

5 or more
week).
17. minutes
Accept those
thingstimes
in mya life
which I can not change.

N

S

O

R

18. Look forward to the future.

N

S

O

R

19. Spend time with close friends.

N

S

O

R

20. Eat 2-4 servings of fruit each day.

N

S

O

R

21. Get a second opinion when I question my health care provider's advice.

N

S

O

R

22. Take part in leisure-time (recreational) physical activities (such as swimming,

N

S

O

R

bicycling).
23. dancing,
Concentrate
on pleasant thoughts at bedtime.

N

S

O

R

24. Feel content and at peace with myself.

N

S

O

R

25. Find it easy to show concern, love and warmth to others.

N

S

O

R
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26. Eat 3-5 servings of vegetables each day.

N

S

O

R

27. Discuss my health concerns with health professionals.

N

S

O

R

28. Do stretching exercises at least 3 times per week.

N

S

O

R

29. Use specific methods to control my stress.

N

S

O

R

30. Work toward long-term goals in my life.

N

S

O

R

31. Touch and am touched by people I care about.

N

S

O

R

32. Eat 2-3 servings of milk, yogurt or cheese each day.

N

S

O

R

33. Inspect my body at least monthly for physical changes/danger signs.

N

S

O

R

34. Get exercise during usual daily activities (such as walking during lunch, using

N

S

O

R

instead
elevators,
car away from destination and walking).
35. stairs
Balance
time of
between
workparking
and play.

N

S

O

R

36. Find each day interesting and challenging.

N

S

O

R

37. Find ways to meet my needs for intimacy.

N

S

O

R

38. Eat only 2-3 servings from the meat, poultry, fish, dried beans, eggs, and nuts

N

S

O

R

each day.
39. group
Ask for information from health professionals about how to take good care of

N

S

O

R

40. myself.
Check my pulse rate when exercising.

N

S

O

R

41. Practice relaxation or meditation for 15-20 minutes daily.

N

S

O

R

42. Am aware of what is important to me in life.

N

S

O

R

142
43. Get support from a network of caring people.

N

S

O

R

44. Read labels to identify nutrients, fats, and sodium content in packaged food.

N

S

O

R

45. Attend educational programs on personal health care.

N

S

O

R

46. Reach my target heart rate when exercising.

N

S

O

R

47. Pace myself to prevent tiredness.

N

S

O

R

48. Feel connected with some force greater than myself.

N

S

O

R

49. Settle conflicts with others through discussion and compromise.

N

S

O

R

50. Eat breakfast.

N

S

O

R

51. Seek guidance or counseling when necessary.

N

S

O

R

52. Expose myself to new experiences and challenges.

N

S

O

R

Scoring Instructions
Items are scored as Never (N) = 1, Sometimes (S)= 2, Often (O) = 3, Routinely (R) = 4
A score for overall health-promoting lifestyle is obtained by calculating a mean of the individual's responses to all 52 items; six
subscale scores are obtained similarly by calculating a mean of the responses to subscale items. The use of means rather than sums of
scale items is recommended to retain the 1 to 4 metric of item responses and to allow meaningful comparisons of scores across
subscales. The items included on each scale are as follows:
Health-Promoting Lifestyle 1 to 52
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Health Responsibility 3, 9, 15, 21, 27, 33, 39, 45, 51
Physical Activity 4, 10, 16, 22, 28, 34, 40, 46
Nutrition 2, 8, 14, 20, 26, 32, 38, 44, 50
Spiritual Growth 6, 12, 18, 24, 30, 36, 42, 48, 52
Interpersonal Relations 1, 7, 13, 19, 25, 31, 37, 43, 49
Stress Management 5, 11, 17, 23, 29, 35, 41, 47

(Walker, Sechrist, & Pender, 1995).
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Appendix D
Herth Hope Index (HHI)
HERTH HOPE INDEX
Listed below are a number of statements. Read each statement and place an [X] in the
box that describes how much you agree with that statement right now.
Strongly Disagree Agree Strongly
Disagree
Agree
1. I have a positive outlook toward life.
2. I have short and/or long range goals.
3. I feel all alone.
4. I can see possibilities in the midst of
difficulties.
5. I have a faith that gives me comfort.
6. I feel scared about my future.
7. I can recall happy/joyful times.
8. I have deep inner strength.
9. I am able to give and receive caring/love.
10. I have a sense of direction.
11. I believe that each day has potential.
212 12. I feel my life has value and worth.
(Herth, 1989)
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SCORING INFORMATION FOR THE HERTH HOPE INDEX (HHI)

Scoring consists of summing the points for the subscale and for the total scale. Subscales
are based on the three factors (see Table 2 in 1992 publication). Total possible points on
the total scale is 48 points. The higher the score the higher the level of hope.
Note the following items need to be reversed scored: 3, 6. Score items as follows:

Strongly Disagree = 1

Disagree = 2

Agree = 3

Strongly Agree = 4

HHI has been translated into Brazilian, Chinese, Dutch, Filipino, French, German,
Icelandic, Italian, Japanese, Korean, Norwegian, Portuguese, Slovenian, Spanish,
Swedish, Tai, Turkish, Urdu.
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Appendix E
Parkinson’s Disease Quality of Life Questionnaire-8 (PDQ-8)
Due to having Parkinson’s disease, how often during the past month have you….. Please
tick one box for each question
Never Occasionally Sometimes
Often Always or
cannot do
at all
1. Had difficulty getting
around in public?
2. Had difficulty dressing
yourself?
3. Felt depressed?
4. Had problems with your
close personal relationships?
5. Had problems with your
concentration, e.g. when
reading or watching TV?
6. Felt unable to communicate
with people properly?
7. Had painful muscle cramps
or spasms?
8. Felt embarrassed in public
due to having Parkinson’s
disease
(Jenkinson & Fitzpatrick, 2007)
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Appendix F
Pre-Notice Study Letter
Given to prospective participants at conference or mailed to their home; first study
contact.
April 23. 2016
First Last Name
Address
City, State, Zip Code
Dear First Last Name,
I am writing to ask for your help with an important study investigating health-promoting
behaviors, hope, and health-related quality of life experienced by persons with
Parkinson’s. Within the next week, you will receive another letter asking you to
participate in this study. The letter will contain surveys related to your level of healthpromoting behaviors, hope, and quality of life.
The reason I am writing in advance is because I want you to have time to think about
participating in my study. I would like to make it an easy and enjoyable process. This
study is part of my dissertation. I am a doctoral student at South Dakota State University
and the study has been approved by the SDSU Nursing Research Committee and the
Office of Research/Human Subjects Committee.
Please consider taking 15-20 minutes of your time to help with the study. I would like
you to have the opportunity to add your perspective on health-promoting behaviors, hope
and health-related quality of life.
Sincerely,
Amy K. Forbes, MS, RN
PhD Student
South Dakota State University
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Appendix G
First Letter Contact
Sent to prospective participants; second study contact
Dear First Name,
Recently you received a letter asking you to respond to study surveys regarding healthpromoting behaviors, hope, and quality of life. Your response to these surveys is helpful
to further understanding of these concepts in nursing practice.
The survey has several components, but should only take you about 15 to 20 minutes to
complete. Please see enclosed surveys.
Everything is kept confidential in this study and no personally identifiable information
will be associated with responses. Your participation is completely voluntary. Please feel
free to contact me at akpeterson1277@jacks.sdstate.edu or my dissertation chair
Kay.Foland@sdstate.edu
I appreciate your help in considering to complete the surveys. Thank you for
participating.
Sincerely,
Amy K. Forbes, MS, RN
PhD Student
South Dakota State University

Dr. Kay Foland, PhD, RN, PMHNP-BC, PMHCNS-BC, CNP
Professor
South Dakota State University College of Nursing, West River
Rapid City, SD
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Appendix H
Thank You Letter Contact
Sent to prospective study participants; third study contact
Dear First Name,
During the last week you were sent surveys regarding the concepts of health-promoting
behaviors, hope, and quality of life. I hope that you have taken the time to complete the
surveys. Please consider taking 15-20 minutes to complete the surveys now. I appreciate
all your help for this important study.
Thanks again for your participation.
Sincerely,

Amy K. Forbes, MS, RN
PhD Student
South Dakota State University
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Appendix I
Permission Emails
3/28/2016
Hi Amy:
You have my permission to use the Health Promoting Life Style II instrument or any
other instruments that seem useful.
Please see attachment with Deep Blue website with the instrument and instructions.
Wishing you good health,
Nola Pender
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Appendix J
Permission Emails

6/17/2016
Dear Amy,
I appreciate your continued interest in the Herth Hope Index (HHI). I have attached a
copy of the HHI, scoring instructions, and two reference lists I have compiled on hope
primarily from the nursing discipline.

You have my permission to use the HHI in your dissertation research project exploring
hope, health-promoting behaviors and HRQOL in persons with Parkinson's Disease. I ask
that you send me a summary of your study findings upon completion of the project.

Best wishes in your educational journey and your important research study.
Sincerely,
Dr. Kaye Herth

Kaye A. Herth, Ph.D., R.N., F.A.A.N.
Minnesota State University, Mankato
Dean Emerita
kaye.herth@mnsu.edu

